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Abstract
The development of real time, label-free biosensors based on ligand-induced
nanomechanical responses of microcantilevers (MCs) allows for sensitive and selective
detection. High sensitivity is afforded by the MCs small dimensions. Immobilizing
biomolecular recognition phases imparts selectivity from bioaffinity interactions.
Biological sensors on a MC platform utilize various proteins, such as antibodies and
nuclear receptors, which can be used to detect and screen for potential environmental
contaminants.
The interaction between contaminants and immobilized receptors induces an apparent
surface stress that leads to static bending of the MC, which is monitored by an optical
beam bending technique.

Biofunctionalized MCs can provide high sensitivity and

selectivity on a relatively inexpensive platform that requires small amounts of analyte.
The goal of this research is to develop and optimize MCs as biosensors to detect low
concentrations of contaminants.
Initially, the research utilized specific receptors and antibodies to detect and screen
for contaminants that are deemed endocrine disrupting chemicals (EDCs). Immobilizing
estrogen receptors and specific antibodies on the MC surface may provide information on
the ever expanding list of EDCs, along with fundamental endocrine studies.
Then, the MC surface was morphologically and chemically optimized.
optimization included the thickness and metal ratio of the dealloyed surface.

This
The

concentration, reaction time, and pH of chemical immobilization reagents, which include
aminoethanethiol and glutaraldehyde, were optimized by using an anti-body test system.
Antibody and protein functionalization conditions, which are incubation time and
iii

concentration, were optimized using the anti-immunoglobulin G (anti-IgG) receptor: IgG
and an anti-biotin:biotin test systems. The optimized immobilization conditions were
applied to the detection of thyroid disrupting chemicals (TDCs) using MCs
functionalized with the transport protein thyroxine-binding globulin.
The final project involved developing a nanomechanical transducer to study
xenobiotic and EDC interactions with the bioreceptor PXR’s ligand binding domain
(LBD).

The combination of immobilized LBD PXR with a nanostructured

microcantilever (MC) platform allows for the study of ligand interaction with the
receptor’s binding domain. PXR shows real-time, reversible responses when exposed to
specific pharmaceutical, EDC, and xenobiotic ligands. Three binding interactions that
involve EDCs are tested, which include phthalic acid, nonylphenol, and bisphenol A,
with PXR.
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Chapter 1 Introduction to Microcantilevers as
Biosensors
1.1 Microcantilevers (MCs)
1.1.1 Microcantilever Background
Microcantilever (MC) popularity grows as chemical and biological sensors as
advances are made in microfabrication. Atomic force microscopy (AFM) cantilever
probes paved the way for the production and use of MCs as sensors. AFM cantilever
probes can vary in response characteristics with environmental changes.

Humidity,

pressure, temperature, and acoustic noise can all contribute to changes on cantilever
probes in AFM (1). In AFM, a flexible cantilever with a tip is scanned in a raster pattern
over a surface where the force between the tip and the surface causes deflection of the
cantilever. This deflection is measured and the topography of the surface can be mapped
(2).

The need for micromachined AFM cantilevers pushed forward advances in

microfabrication technology.
In 1994, researchers began to take advantage of AFM cantilevers and utilize them
as sensors (3,4). This ushered in MCs, AFM cantilevers without the tip, as a new
physical and/or chemical sensor with excellent sensitivity. MCs are simple mechanical
devices that can be bulk fabricated and are typically 0.2-1 µm thick, 20-100 µm wide,
and 100-500 µm long. MC chips can be fabricated using routine photolithographic
patterning and a combination of bulk and surface micromachining (5).

Bulk

micromachining removes a large portion of the substrate. It is often utilized when
fabricating suspended structures. Surface micromachining keeps much of the original
1

substrate intact and is used as the base for devices created through deposition and etching
processes. Single crystal silicon is the preferred material for MC fabrication. Usually,
MC fabrication consists of deposition, patterning, and etching steps. These steps define
the MC thickness, lateral size, and surrounding lever area. MC fabrication commonly
begins with the deposition of a sacrificial layer on a prepatterned substrate. Then, a
silicon nitride or a polysilicon structural layer is deposited using low pressure chemical
vapor deposition (LPCVD) or plasma-enhanced chemical vapor deposition (PECVD) on
the sacrificial layer. Cantilevers shapes can be patterned by photolithography on the
silicon nitride film followed by reactive ion etching (RIE). The silicon substrate is then
etched away leaving free-standing cantilevers (6). The promise of MCs as sensors not
only lies in it’s small size, but also it’s relatively low cost, disposable platform, easy
integration or coupling with other methodologies (separations, spectroscopy), generally
quick response time, and array capabilities. MCs are one part of microelectromechanical
systems (MEMS), which involve transduction of mechanical energy in sensors. MEMS
sensors rely on mechanical movements and deformations of their micromachined parts,
which can include single-clamped suspended beams (cantilevers). MEMS sensors as
micromechanical transducers can be affected by physical, chemical, or biological stimuli
that can induce changes, which can be measured electronically, optically, or by other
means. MCs can detect changes in surface stress, small mechanical forces, charges,
temperature, and IR photons (6).

2

1.1.2 Comparative Sensors
Comparing MCs to traditional sensors, like quartz crystal microbalance (QCM)
and surface acoustic wave (SAW) transducers, demonstrates their excellent sensitivity
(5). QCMs are mass sensitive sensors that utilize the change in frequency of the quartz
crystal resonator when material is deposited on the surface (7). SAWs are also mass
sensors that use alternating voltage on two interdigital transducers. This creates a surface
wave on the piezoelectric substrate such that the amount of material deposited between
the transducers can be measured due to the change in the surface wave velocity and
therefore frequency (8).

QCM sensors are limited when placed in viscous liquids,

whereas SAW sensors are constrained when placed in any liquid. These limitations are
both related to frequency dampening. Compared to QCM and SAW, MCs have much
better sensitivity to minute quantities of adsorbates (5).

1.1.3 MC Measurement Modes
MC sensing can be measured in two modes: dynamic and static. Each mode has
it’s own advantages and should be chosen depending on the medium it will be used in
and what response mechanism is involved.

Resonant or dynamic mode can use

oscillation dampening to measure mass changes on the MC surface (6). Measuring the
change in resonance frequency may indicate analyte binding to a molecular recognition
phase (MRP) on the MC surface. Resonance frequency, ƒ, of an oscillating cantilever
can be expressed as equation 1 (9)

f = 1 (2π ) × ( K / m∗)

3

(1)

where K is the MC spring constant, m* is the effective MC mass. Effective MC mass is
related to the beam or lever mass, mb, through equation 2 (9)
m* = nmb

(2)

where n is the geometric parameter. Resonance frequency changes, from ƒ0 to ƒ1, due to
mass changes, ∆m, can be expressed through equation 3 (5)
1 f 12 − 1 f 02 = ∆m (4π 2 K )

(3)

where K is the MC spring constant. Dynamic or resonant mode has low sensitivity,
which has been used to detect bacteria and single cell virus particles (10, 11). Resonant
mode of MCs consists of three mechanisms, adsorbate-induced mass-loading, chemical
changes of cantilever stiffness, and dampening by the viscous medium (6).

A

disadvantage of dynamic mode is the dampening that can occur in liquid media, which
may reduce sensitivity (9). Dynamic mode is still used in liquid or aqueous media
depending on the mechanism being studied. Dareing, et al. have demonstrated that the
frequency shift due to dampening is small compared to the frequency shift induced by
changes in effective mass (12).
Static mode measures the deflection of the MC tip or simply the bending of the
MC. Cantilever deflections may be caused by either external forces on the surface or
stresses generated on or in the lever (6). One must establish asymmetry on the MC by
creating two sides to the lever, an active and passive side, to measure the deflection or
bending due to analyte binding. The active side is functionalized with a MRP that has
some degree of affinity for the analyte, whereas the passive side does not have affinity for
the analyte molecule. There are various models to consider on how different coatings
4

provide chemical responses on MC sensors working in static bending mode. When
interactions between the MC and its environment are purely surface confined, an example
being chemisorption of straight-chain thiol molecules on a gold-coated cantilever, the
spontaneous adsorption processes are driven by an excess of interfacial free energy. This
is typically accompanied by a reduction of interfacial stress. The surfaces usually expand
as a result of adsorptive processes. This type of surface stress change is defined as
compressive, referring to the possibility that the surface may return to its original
compressed state. When a MC is modified with an analyte-permeable coating that is
much thicker than a monolayer, the interactions of the analyte molecules with the bulk of
the responsive phase are taken into account. A predominant mechanism of cantilever
deflection in this case is described as analyte-induced swelling of the coating. Such
swelling processes can be quantified by evaluating molecular forces acting in the coating
and between the coating and the analyte species. In general, dispersion, electrostatic,
steric, osmotic, and salvation forces acting within the coating can be altered by absorbed
analytes (13). The changes of these forces within the coating can cause stress changes
which are imparted on the cantilever causing deflection. When nanostructured interfaces
and coatings are used, analyte-induced deflections of cantilevers combine mechanisms of
bulk, surface, and intersurface interactions.

A combination of these mechanisms

facilitates efficient conversion of the energy of receptor-analyte interactions into
mechanical energy of cantilever bending (5). Regardless of the active side MRP surface
stress method, the static bending or tip deflection, zmax, of the MC varies depending on
the preferential binding of analyte molecules to the active, functionalized side of the lever
and is governed by Stoney’s equation (14)
5

z max = 3l 2 (1 − ν ) ∆σ Et 2

(4)

where ν and E are, respectively, the Poisson ratio and Young’s modulus for the
cantilever, t is the MC thickness, l is the MC effective length, and ∆σ is the analyteinduced differential surface stress (∆σactive

side

– ∆σpassive

side)

(Fig. 1). This deflection

measuring method is commonly used in AFM. The MC static bending mode functions
well in both liquid and gas media, since it has no dependence on the resonant frequency
of the MC. In the research presented herein, the static bending mode is used with MCs
that are nanostructured for increased sensitivity and functionalized with MRP for
selectivity. Static mode is preferred since all measurements were made in liquid phase
which leads to significant damping of MC oscillations and hampers dynamic mode
monitoring. Furthermore, mass changes are many times miniscule due to the use of very
large immobilized bioreceptors with very small ligands.

1.1.4 Static Mode Instrumentation
Typically, a MC static bending mode or tip deflection instrumental setup consists
of seven main parts: a diode laser, lenses, a neutral density filter, a position sensitive
detector (PSD), a microfluidic cell, the MC chip and an output device or recorder, as seen
in Fig. 2. We have extensively studied our single laser static bending mode setup using
MCs that are 400 µm in length, 100 µm in width, and 1 µm thick and determined that a 1
mV response corresponds to approximately 1 nm of MC bending. The microfluidic cell
is designed to flow background and analyte solutions past the MCs. A well designed
flow cell requires low volumes and has a thorough, quick washout of analyte solution and
can be utilized with a pump or gravity flow. Static bending mode can utilize the optical
6

l
t
z

Fig. 1. The static bending of the MC. Tip deflection or bending is illustrated.
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CCD camera

mirror
PSD

Flow cell
Diode Laser

Lens

NDF

Fig. 2. MC static bending mode setup: The diode laser passes through a

series of lenses and a neutral density filter then onto the MC tip in the
flow cell. The reflected laser light goes onto a mirror and into a PSD.
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beam deflection technique. This optical readout method focuses a laser beam on the tip
of the lever which is reflected onto a PSD as illustrated in Fig. 3. The PSD quantifies the
MC deflection or bending. The optical lever readout scheme is commonly used in AFM
instruments. The absence of electrical connections to the cantilever, linear response,
simplicity, and reliability are important advantages of the optical lever method. This
method is used in the vast majority of the work on cantilever sensors, so its limitations
are well recognized. For instance, changes in the optical properties of the medium
surrounding the cantilever may interfere with the output signal. This interference can be
avoided with the proper orientation of MCs relative to the optical components of the
setup. Refractive index changes can affect the output signal as well. Using differential
pairs or arrays of cantilevers can suppress the refractive index changes as well as other
interfering factors (6). Microcantilever arrays (MCAs), which differentially functionalize
individual levers on the same chip with various MRPs, use slightly different optical
system instrumentation (19). A beam of laser light from an array of vertical cavity
surface emitting lasers (VCSELs) is focused onto the tip of each MC, and the reflected
beam is captured and monitored by a single PSD. A single lens is used to focus the
VCSELs so that the beam from each VCSEL is focused onto a single corresponding
cantilever (12 VCSELs onto 12 cantilevers). The deflection of the cantilever results in a
corresponding motion of the reflected beam as monitored by the PSD. The entire cycle
of measuring and recording all 12 MCs can take less than one second. This allows all
MRPs on different levers to be monitored within a second.

9

Fig. 3. Beam bending optical readout method: The PSD measures the

movement of the reflected laser light when the MC bends upon analyte
binding to the molecular receptor phase.
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1.2 Molecular Recognition Phases
Molecular recognition phases can include a variety of compounds, including but
not limited to polymers, cyclodextrins, proteins, antibodies, metals, and sol-gels (5, 6, 9,
15-18). The use of MRPs promotes selectivity that is not inherent to MCs. Spectroscopy
provides a vibrational fingerprint to chemicals and compounds, where MC responses do
not provide that characterization. The use of an appropriate MRP responds to an injected
analyte with a unique response signature, but this does not impart the characteristic
vibrational bands for analytes that is present in spectroscopy. This necessitates the need
for selective MRPs. There are two methods for utilizing MRPs to impart selectivity:
moderately selective MRPs for distributed selectivity and bioaffinity or high affinity
MRPs. Distributed selectivity functions in an array platform (see above) providing
response patterns for analytes. Chemical selectivity may be demonstrated by using a
large number of moderately selective MRPs and pattern recognition algorithms to
examine the unique analyte responses (19). Disadvantages of the distributed selectivity
method may arise with the complicated data sets if there is not enough contrast between
the response profiles or the amount of time and difficulty that surrounds creating arrays
with many MRPs. Bioaffinity or high selectivity MRPs (biosensors) provide selectivity
by exploiting the high affinity interaction or binding that is inherent to many biological
receptors to specific analytes (15, 20, 21). Disadvantages of the bioaffinity method may
include reversibility issues and the robustness of the immobilized bioreceptor.

11

1.3 Biosensor Overview
1.3.1 Biosensor Capabilities
Chemical sensors and biosensors are defined as measurement devices which
utilize chemical or biological reactions to detect and quantify a specific analyte or event
(22). A sensor converts physical dimension changes to an electrical component that can
be processed or electrically transmitted (23). Components of a sensor include an active
surface, physical transducer, and an output of the signal. The active surface contains the
immobilized receptor and the interaction between the receptor and the analyte is detected
by a transducer. The interaction causes a change, usually a binding event, that the
transducer expresses as a signal or response, which can include changes in impedance,
frequency, voltage, reflectance, or weight (22).
Chemical and biosensor development began over 90 years ago. In 1916, Nelson
and Griffin first reported the immobilization of proteins on activated charcoal (24) and
six years later the first glass pH electrode was developed by Hughes (25). A sensor’s
purpose is to provide information about the physical, chemical, and biological aspects of
the environment. The demand for more information has motivated the expansion of
chemical and biosensors. In general, sensing consists of two steps, which are recognition
and amplification (26). The central component to any chemical sensor is selectivity or
recognition with biological components being one of the most prevalent sources (27). A
sensor requires some fundamental properties which include sensitivity and reversibility
and for many applications a quick response time is also important. Sensors should also
possess some general requirements to be useful to the user. These may include good
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reproducibility, dynamic range, stability, and a long life or problem free sensor
replacement (23). “Good” is a relative term that often depends on the type of sensor and
the analyte in question. Often it is the physical transducer that imposes limits on the
figures of merit that can be achieved by a specific sensor (6).

1.3.2 Types of Biosensors
Biosensors are a constantly expanding field that is needed for many applications,
which can include medical and pharmaceutical applications, as well as environmental
research.

There is a broad spectrum of biosensor types depending on the specific

function or purpose. This can include many popular and well established biological
sensing methodologies. Enantioselective sensors are used to determine the presence of
enantiomers of chiral compounds (21, 28-30).

This is of crucial importance to

pharmaceutical companies since many of the drugs in development are chiral.
Enantiomers of a chiral pharmaceutical agent can have very different effects on the body,
some of which can be detrimental.
Enzyme-linked immunosorbent assay (ELISA) is a biochemical technique used to
detect binding of biochemicals or bioreagents which can be quantified by determining the
amount of color change or generated color that occurs upon ligand binding. This requires
an enzyme to be chemically attached to a labeled antibody before ligand binding. This is
a very common assay for determining binding events for a specific receptor. It can be
used for various applications, which include detecting environmental contaminants with
bioreceptors, screening for drugs of abuse, and detection of hormones in various
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chemicals (31-35). ELISA can be used to determine equilibrium disassociation constant
for receptor and ligand interactions (36). Drawbacks of ELISA based methods can
include long, multistep assay preparation with labels and multi-step enzyme-ligandreceptor interactions, which may not provide real-time results and may not measure trace
concentrations of ligands.
Radioligand binding assays are another well established method for detecting
binding events for biological entities (37-41). In this type of assay the antibody is labeled
with a radioactive isotope. This radioactively labeled antibody or protein is commonly
termed a tracer.

Equilibrium constants for binding of analyte and receptor can be

determined with radioligand binding assays. In one assay method, the radioligand is
displaced from the receptor by a higher affinity analyte and the radioactive decay is
measured.

This method is considered to be very sensitive utilizing high-affinity

interactions and may require small concentrations of ligand or analyte (36). Radioligand
binding assays require labeling with radioisotopes, which require special protocols for
handing and stringent disposal regulation (22).
Competitive binding immunoassays usually require antigens (see below) to
compete for a limited number of antibody binding sites. A determined concentration of
labeled antigen competes with unlabeled antigens for the antibody binding sites. In this
method, competitive assays are reagent limited. The signal produced by the labeled
antigen is inversely proportional to the concentration of the unlabeled antigen. There are
many experimentally specific variations to this assay. Competitive assays can be used for
various applications, which include detecting small molecules, exogenous chemicals, and
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contaminants binding with bioreceptors (41-45). A good review of biosensing methods
can be found in The Immunoassay Handbook edited by David Wild (46).

1.4 Protein and Antibody Significance
Proteins and antibodies (Abs) can be considered ideal receptors in producing
sensor selectivity. This is in part due to the stereospecificity of their ligand binding site
which can be specific to certain antigens and haptens (26). A protein is defined as a
macromolecule composed of one or more polypeptide chains, each with a characteristic
sequence of amino acids linked by peptide bonds (47). Proteins encompass a large group
of biological compounds, which include antibodies and enzymes and may be the most
adaptable of all biomolecules.
Antibodies are key elements for studying many biological processes. An antibody
is a serum protein that is part of the immunoglobulin family. Their molecular weights
range from 140 kD to 970 kD (26). It is produced by humans and animals in an immune
response to foreign substances or antigens (Ags). The immunoglobulin family is made
up of many subclasses which include immunoglobulin A (IgA), IgD, IgE, IgG, and IgM.
The class that is responsible for the majority of antibody immune response is IgG. IgG is
one of the most commonly used antibodies in immunoassay and biosensor development
due to it’s widespread availability and large research literature base. IgG is a Y-shaped
biomolecule comprised of four polypeptide chains, two identical heavy chains and two
identical light chains that are connected by disulfide linkages (Fig. 4). The molecular
weight of IgG is approximately 150,000 Daltons, where each heavy chain is 50,000 Da
and each light chain is 25,000 Da. Antibodies can be digested to three portions or
15
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fragments, which are Fab, F(ab’)2 and Fc. The Fab and F(ab’)2 fragments are responsible
for antigen binding. Antibody production is universal and relatively inexpensive. An
immune response to almost any antigen can illicit antibodies, regardless of the shape or
chemical makeup of the antigen. Antigen size is the only limitation that has to be
overcome. Antigens with a molecular weight of less than 2000 Da is defined as a hapten
and does not normally produce an immune response on it’s own. To induce an immune
response and generate antibodies the hapten is linked to a larger carrier, which can be a
high molecular weight polymeric carrier (26).

The generated antibodies provide

specificity to the hapten and the carrier molecule, so the hapten specific antibodies need
to be filtered out of the carrier specific antibodies. This allows antibodies to be produced
to substances, like haptens, that are normally unrecognizable to the immune system.
Once the antibody response occurs the IgG can be isolated from the whole serum. Later
in this chapter and in Chapter 4, I discuss a class of proteins that do respond to and
eliminate small foreign molecules.
Antibodies can be either monoclonal or polyclonal.

Both types are useful

depending on their application. Polyclonal antibodies (PAbs) result from an injected
antigen stimulating production of many antibodies, recognizing several epitopes on the
antigen. Due to the heterogeneity of the PAbs, the effect of small changes in an antigen
epitope is less likely to be significant. PAbs are produced by a large number of B cells in
response to the antigen and are therefore a combination of antibodies with unique
specificities. Kohler and Milstein first developed monoclonal antibodies (MAbs) by
fusing single B-cells with immortal myeloma cells producing a hybridoma that can yield
multiple copies of the exact same antibody (48). MAbs are homogenous and consistent
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making them useful when evaluating conformational changes or protein interactions.
This homogeneity makes them more susceptible to small changes in epitope structure.
MAbs are constantly generated once a hybridoma is successfully created and are
generated at a higher concentration and purity for a given antibody than PAbs. MAb
generation is expensive, time consuming, and requires considerable technical skill
compared to PAbs. Generally, PAbs are more robust, can be generated by a variety of
species, and are more tolerant of small conformational changes in the antigen. MAbs are
excellent primary antibodies due to their specificity and yield reproducible results
because of their homogeneity.
Antibody specificity for a target antigen is better than most MRPs. Antibodies
should be able to bind to a small concentration of analyte even in the presence of other
similar compounds. The average binding of PAbs and an antigen is termed avidity and
the binding equilibrium is called affinity. For MAbs avidity and affinity are the same due
to their inherent homogeneity.

The most common interactions in immunochemical

reactions between an antibody and an antigen are coulombic and van der Waals
interactions. Typical affinity constants or equilibrium constant values for IgG are 105-109
L/mol. At equilibrium, the antibody –antigen binding can be shown as
kf

Ab + Ag ⇔[ Ab. Ag ]
kr

(5)

where the binding constant K is defined by the forward and reverse rate constants. The
forward rate constant range is 107-109 L mol-1 s-1 and the reverse rate constant range is
10-2-104 s-1 (26).
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1.5 Immobilization of Bioreceptors on the MC Surface
1.5.1 Nanostructured MC Surface
The key approach to enhance the sensitivity of chemi-mechanical responses is to
employ nanostructured gold MC surfaces. The active side of the MC is nanostructured to
increase surface area, which in turn inherently increases sensitivity. Nanostructured
responsive phases increase the amount of binding sites per cantilever, but still allow
analyte accessibility (6). To create the nanostructured surface in our approach, gold and
silver are co-deposited in a physical vapor deposition (PVD) chamber. The alloy is
chemically altered to remove the silver via oxidation using HAuCl4, leaving a granular,
porous dealloyed gold surface. This process is illustrated in Fig. 5. The PVD instrument
operates under high vacuum (1x10-3-1x10-9 Torr) using a mechanical pump and a
diffusion pump.

The mechanical pump initially pumps down the system from

atmospheric pressure to ~1x10-3 Torr, and then the diffusion pump pulls the system down
to ~1x10-6 Torr. The metals to be deposited (chromium, gold, and silver) reside in small
tungsten boats that are held in electrodes. The metals are electrically heated causing
evaporation and metal deposition onto the MC surface. The rate of deposition and metal
thickness on the MC are measured by a QCM, respectively. The PVD creates an alloy
surface that is then chemically altered to dealloyed, as described above. In some cases,
utilizing dealloyed MCs provides a two order of magnitude response enhancement (16,
49).

The dealloyed surface enhances the transduction of molecular recognition

interactions into MC responses, increases MC surface area, increases sensitivity, and
provides for film stability for thicker MRPs (17). When an unfunctionalized
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Fig. 5. Depositing dealloyed: Co-deposition of gold and silver in the physical

vapor deposition chamber creates a composite layer (alloy). The alloy chip is
then placed in HAuCl4 solution to remove the silver, leaving a nanostructured
gold surface (dealloyed).
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nanostructured MC surface is exposed to Abs, the resulting response from physical
adsorption is large, reversible, and tensile, whereas the smooth gold MC surface response
is much smaller, reversible, and compressive (expansive) (21). The advantages to using
dealloyed MCs include much improved sensitivity and coating stability.

1.5.2 Chemical Immobilization
Chemically linking the bioreceptor to the MC surface provides for stability when
flowing aqueous buffer background and when injecting analyte solutions. Concern arises
that the active bioreceptor binding sites will be distorted or blocked when chemically
immobilizing to the MC surface, which would not allow the analyte to interact with the
receptor (see Chapter 3). Studies have shown that random chemical linkages leave an
appreciable concentration of receptor sites active (15, 20, 21, 50). To chemically modify
the dealloyed surface in our work, the MCs are immersed in 2-aminoethanethiol
hydrochloride (AET) producing a self assembled monolayer (SAM). The use of SAMs to
functionalize a solid support, like gold, has become important in the field of
biotechnology, and in particular biosensor development due to the simplicity (51). In
1983, Nuzzo and Allara developed a structural understanding of thiol organization on a
gold surface (52). Advancements have continued and today many useful modification
agents have been used to form functioning surface coatings on solid supports.
The amino groups on the AET are derivatized with glutaraldehyde (GA), which is
one of the most common crosslinkers for bio-immobilization. The GA is a linker for the
bioreceptor to the AET nanostructured gold surface. Common crosslinking agents are
glutaraldehyde, hexamethylene diisocyante, difluoro-dinitrobenzene, and dimethyl
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suberimidate.

Crosslinkers are used to polymerize a base layer and to anchor the

bioreceptor molecule to the sensor surface. The anchoring is a result of intermolecular
linkages between the surface and the receptor, which provides a more stable MRP on the
sensor. The crosslinker and it’s concentration are critical, so that it will not interfere with
the bioreceptor’s activity (22).

GA’s optimal concentration varies depending on

experimental use, therefore the conditions must be determined on a case by case basis.
The aldehyde in GA binds with the amine in the AET. A Schiff base reaction occurs
between the carbonyl group of the GA and the lysine residues in the proteins, through the
amines in the residue (53, 54). This results in the GA link between the AET and the
protein (Fig. 6).

GA is not thought to appreciably denature the proteins upon

immobilization (55, 56). Studies have shown that the immobilization method into the
MC surface does not significantly alter the ligand binding domain (LBD) of the
bioreceptor (15, 20, 21, 50).

1.6 Ligands and Analytes
Analytes that are specific for protein functionalized MCs have a broad range,
which can include antigens specific for antibodies, environmental contaminants,
pharmaceuticals, metals, and various chemicals.

Their size can range from small

molecules (haptens) to large complexes, like many pharmaceutical compounds. Analytes
or ligands stimulate the immobilized bioreceptor, usually by interacting with the LBD(s)
of the protein or the Fab portion of antibodies. To translate this interaction to MC surface
stress, which causes a measureable deflection, a conformational change of the
immobilized protein maybe required. In some bioreceptors, the conformational change in
22
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the LBD upon analyte binding can cause changes in a DNA binding region of the
receptor protein. This overall receptor conformational change may yield relatively large
nanomechanical bending, especially if the immobilization occurs at the DNA binding
site, making it a good candidate for MC sensing studies. Environmental contaminants,
whether naturally occurring or synthetic, and pharmaceuticals are included as analytes or
ligands for biosensors and bioassays with immobilized receptors. Contaminants can
include organohalogenated hydrocarbons, polychlorinated hydroxybiphenyls (PCBs),
insecticides, herbicides, plasticizers, and detergent byproducts. The human diet contains
several nonsteroidal, weakly estrogenic compounds that are from plants and can act as
contaminants within the body by inhibiting key system bioreceptors. These plant derived
chemicals are phytoestrogens, which plants produce themselves, and mycoestrogens,
which are from fungi that infect the plant. Phytoestrogens consist of three main groups:
flavonoids, coumestans, and lignans. Mycoestrogens are mainly zearalenone and it’s
derivatives. Mycoestrogens are associated with estrogenizing syndromes in cattle that are
fed fungi infected grain. Phytoestrogens and mycoestrogens have been linked to cell
mitosis in breast cancer cells in vitro and compete with estrogens for their natural
estrogen receptor. However, some studies show that phytoestrogen intake is linked to
lower rates of prostate and breast cancer (40, 57). Phytoestrogen and mysoestrogen
studies show that contaminate screening is an important and sometimes arduous task.
Determining contaminates that have adverse health effects is not always an easy and
straightforward task.
Hormones and pharmaceuticals are important ligands for our biosensors. This can
include estrogens, steroids, antibiotics, and many other medications. Sometimes the line
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can be blurred between drugs and contaminants. Medication that is widely prescribed
can sometimes be considered a contaminant due to it’s presence in the environment.
People can ingest these pharmaceuticals/contaminants, from drinking water, etc., without
their knowledge, which may alter receptors and transport proteins functions.
Some metals, like cadmium, bind to receptors and block binding by the natural
ligand. Cadmium can be found in the air, water, and soil, therefore it can be inhaled or
ingested. Once in the body, it may not be expelled, but can be stored in the lungs, liver,
and kidneys. Cadmium has been shown to activate or bind to estrogen receptors, which
could hinder it’s natural activity, as presented in Chapter 2 (15, 58). Other metals,
including lead, copper, and mercury, are considered contaminants that can cause adverse
health effects. Therefore, some metals can be considered analytes for biosensors when
studying environmental contaminates.

1.7 Estrogen Receptors and Thyroid Proteins
1.7.1 Estrogen Receptors
Estrogen receptors and thyroid proteins are both part of the endocrine system.
The endocrine system includes glands throughout the body, which produce or transduce
hormones, and the tissues and organs that respond to hormones. Major components
include the ovaries, testes, and the pituitary, thyroid, and adrenal glands, but the effects of
the endocrine system are throughout the entire body. The endocrine system processes
include regulating metabolism, blood sugar levels, reproductive functions, and the brain
and nervous system functions. An extremely wide range of biological processes are
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influenced or controlled by the endocrine system, which include many bioreceptors like
estrogen receptors and thyroid transport proteins.
Estrogen receptors, which exist in two forms, ER-α and ER-β, are part of the
nuclear receptor family. They have similar affinities for most ligands, like estradiol, but
can have different relative affinities for some synthetic and naturally occurring ligands.
Some body tissues show a higher concentration of one subtype’s ribonucleic acid (RNA).
The kidney, uterus, pituitary, and epididymis contain more ER-α RNA than ER-β. ER-β
is present in equal or greater quantities in the ovary and prostate. Estrogens, which are
complementary hormones to estrogen receptors, have effects on the male and female
reproductive systems, bone maintenance, and many other tissues throughout the body.
Estrogen plays a role in many organs, including those of the cardiovascular, nervous,
reproductive, and musculoskeletal systems (59). Estrogen is produced mainly in the
ovaries and testes, where they are free to diffuse in and out of cells. They are retained by
estrogen receptors due to their high affinity and specificity. Once estrogen- ER binding
occurs the estrogen receptor undergoes a conformational change permitting the receptor
to bind to chromatin within a cell’s nucleus and control transcription of target genes (60).
In the 1950’s, pregnant women, who were deemed at risk, were given diethylstilbestrol
(DES), a potent synthetic estrogen thought to prevent first trimester miscarriages, early
during their gestational period.

Their male offspring had increased incidence of

undescended testes, urogenital tract abnormalities, and reduced semen quality compared
to boys whose mothers did not take DES (61). This demonstrates one way synthetic
estrogens can cause major health problems by disrupting the normal estrogen receptor
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binding events and the transcription they stimulate. Many other pathways exist for
exogenous compounds to cause adverse health issues that need to be studied.

1.7.2 Endocrine Disrupting Chemicals (EDCs)
Estrogen receptors can be impaired or inhibited by environmental contaminants,
which can have sometimes detrimental effects on the endocrine and reproductive
systems. These contaminants are called endocrine disrupting chemicals (EDCs). They
comprise a wide and ever expanding range of naturally occurring and synthetic chemicals
and their byproducts, which include pesticides, plasticizers, detergents, pharmaceuticals,
and some biological compounds excreted by animals or plants (Fig. 7) (62, 63). EDCs
like bisphenol A can leach from plastic into foods, as shown in canned foods which are
lined with polycarbonate lacquers. Many workers who manufactured or sprayed large
crops with insecticides have lower sperm counts, and some became impotent, due to the
estrogenic activity of the insecticide (64). Humans, wildlife, and livestock are exposed to
EDCs in many ways. EDCs can disrupt the endocrine system often resulting in chronic,
debilitating health problems by mimicking or inhibiting the natural hormone (40, 58, 65).
It is critical to identify potential EDCs so action can be taken to eliminate their effects.
The Environmental Protection Agency (EPA) instituted the Endocrine Disruption
Screening Program to screen and test chemicals to identify potential EDCs and assess and
manage the risks of particular compounds (65). In Chapter 2, ER-α and ER-β are used to
screen and detect for EDCs.
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1.7.3 Thyroid Transport Proteins
Thyroid proteins are another important component to the endocrine system.
There are three main thyroid hormone binding proteins in the blood: thyroxine binding
globulin (TBG), transthyretin (TTR), and serum albumin (ALB). These bind to and
transport thyroid hormones in the blood. L-thyroxine (T4) is the main hormone of the
thyroid system and a highly prescribed pharmaceutical in the United States. TBG, which
is synthesized in the liver, is the main T4 transporter in human blood responsible for 75%
of it’s binding activity, while TTR only carries roughly 20% and ALB only 5% of T4.
TBG is present in plasma at lower concentrations than other transport proteins, but carries
the largest percentage of T4. This is due to TBG’s high affinity to T4. TBG’s affinity is
100-fold higher for T4 than the other two transport proteins (66). Although TBG has
greater affinity to T4, TTR is crucial to T4 transport across the brain barrier and maternal
to fetal delivery of thyroid hormones. TBG has one T4 binding site and TTR has two,
each with different affinities for T4. TTR and TBG are similar in size (55 kDa and 54
kDa), but differ in their affinities for T4 and triiodothyronine (T3), which is a natural
thyroid hormone in the body. T4 and T3 are two thyroid hormones, each containing
multiple iodine atoms (four iodine atoms in T4 and three iodine atoms in T3), which
makes them large in size and imparts important protein binding features due to the
electronegativity of the iodine atoms (67). T4 and T3 appear to have an effect on nearly
every organ and tissue of the body. These thyroid hormones are critical to normal growth
and development and effect protein synthesis in many tissues (68). It has been suggested
that hypothyroidism results in the displacement of T4 by contaminants when under
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transport by TTR, therefore the study of thyroid hormone transport is an important aspect
of thyroid disruption (69). TBG seems to be quantitatively more valuable than TTR for
T4 transport, so Chapter 3 includes TBG screening and detection of contaminants.

1.7.4 Thyroid Disrupting Chemicals (TDCs)
Thyroid disrupting chemicals (TDCs) are a subclass of EDCs that have thyroid
activity, which can include organohalogen compounds.

Previous studies have

demonstrated that organohalogen chemicals can have adverse affects on the thyroid gland
morphology and hormonal balance in rats (70). The disruption or inhibition of the
thyroid system may cause health problems and disease. They may have adverse affects
on the thyroid gland, thyroid transport proteins, and/or thyroid hormone metabolism (37).
Even trace concentrations of EDCs and TDCs may cause disruption of the endocrine
system. A broad class of chemicals present thyroid activity, so screening for this growing
list of TDCs is important.

TDCs can disrupt the transport of thyroid hormones

throughout the endocrine system.

1.8 Pregnane X Receptor (PXR)
1.8.1 Nuclear Receptors
Nuclear receptors are soluble, intracellular proteins that bind steroid and hormone
ligands and other compounds. They bind to hormone ligands with high affinity and
interact with specific DNA target elements.

Nuclear receptors are responsible for

regulating transcription of various genes making them crucial to many physiological
processes. Lipophilic hormones, including steroids, retinoids, and thyroid hormones, are
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able to move freely through cells.

These hormones regulate development, cell

differentiation, and organ physiology. Tracking hormone movement with radiolabeled
ligands allowed the identification of binding proteins. The binding proteins were able to
move from the cytoplasm to the cell nucleus. Steroids were proven to be tissue specific
by the presence of high binding affinity receptors located in the tissue. Together this
allowed the recognition of a steroid hormone signaling pathway. The identification of
this pathway suggested that nuclear receptors when bound to hormones complexed with
chromatin in the nucleus and regulated transcription. Nuclear receptors are characterized
by a central DNA binding domain and the LBD located on the C-terminal half. The LBD
assures specific hormone recognition and can morph the receptor into a transcriptionally
active state. Nuclear receptors are part of a superfamily with hundreds of identified
receptors. There are also many orphan nuclear receptors, which have no recognized
specific ligand (71). Estrogen and thyroid receptors are members of the nuclear receptor
superfamily.

1.8.2 PXR Significance
Pregnane X receptor (PXR) is a promiscuous, orphan nuclear hormone receptor
that is activated by a wide range of exogenous compounds. It was isolated in 1998 by
Bertilsson, et al., Blumberg, et al., and Kliewer et al. and called PXR, steroid and
xenobiotic receptor (SXR), pregnane activated receptor (PAR), and NR1I2 (72-75). PXR
is expressed mainly in the liver and intestine. Humans are exposed to a myriad of
potentially toxic chemicals on a daily basis, so the body has developed a line of defense
mechanisms.

The main defender is the family of cytochrome P450 enzymes for
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mammals, which includes cytochrome P450 monooxygenases: CYP1, CYP2, CYP3, and
CYP4 (76).

Cytochrome P4503A4 (CYP3A4) is a critical member of our defense

system, which makes the removal of many unwanted exogenous compounds possible by
metabolizing them from the body (77). PXR may be considered the first line of defense.
When PXR binds with xenobiotic ligands this interaction causes transcriptional activation
of CYP3A4, which may remove unwanted potentially toxic ligands (78). PXR is called a
promiscuous receptor due to it’s broad ligand specificity, which allows activation by a
wide array of structurally diverse xenobiotics (79). This promiscuity makes it unlike
most other types of hormone receptors, which are highly selective to their complementary
hormone. This extremely wide ligand activation range is made possible by it’s unique
LBD, which has two β strands that are not present in other nuclear receptors and that
allow it’s expansion (80). Rifampicin, a potent PXR activator, is a macrolide antibiotic
that is a commonly used treatment for tuberculosis. It is also one of the largest known
ligands for PXR at 823 Da (81). Rifampicin’s large size directly illustrates the structural
flexibility of PXR’s LBD. The flexible, hydrophobic LBD allows PXR activation by a
diverse range of synthetic and naturally occurring chemicals making it an ideal candidate
to serve as a xenobiotic sensor (82).

1.8.3 PXR and Pharmaceuticals
PXR could be a key nuclear receptor in pharmaceutical testing because it is
activated by numerous pharmaceuticals with diverse properties, functions, and structures.
PXR also controls the expression of genes that are vital to pharmaceutical and
contaminate metabolism (81, 83).

PXR activation mediates transcription of CYP
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enzymes, including CYP3A, and many other enzymes and transporters within the body
(82). CYP enzymes are considered drug metabolizing enzymes and are already involved
in assays for drug development (76). Since, PXR activation allows for regulation and
expression of CYP3A this interaction is critical to drug metabolism (77). Pharmaceutical
metabolism and interaction is vital to monitor and prevent drug-drug interactions. Drugdrug interactions can occur when co-administered drugs alter the efficacy of one another.
This usually occurs when one drug increases or decreases the metabolism of another (84,
85). Contaminants could modify drug concentrations in vivo and skew the prescribed
therapeutic dose leading to fatal consequences.

Drug-drug interactions can include

common over-the-counter herbal and dietary supplements. Hyperforin, a compound in
St. John’s Wort, which is commonly used to treat depression, has been shown to be a
powerful PXR activator (86).

It is common practice to combine over-the-counter

supplements with prescriptions, but since supplements may cause PXR activation, this
could alter the efficacy of vital medications.

Determining drug-drug and drug-

contaminate interactions is critically important for human health and pharmaceutical
development. In Chapter 4, we study PXR nanomechanical responses to exogenous
chemicals, which include pharmaceuticals and EDCs.
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Chapter 2 Development of a Nanomechanical
Biosensor for Analysis of Endocrine Disrupting
Chemicals
Chapter 2 is an adaptation of a research article Lab on a Chip 2007, 7, 1184-1191.
The article demonstrated that estrogen receptors and estradiol antibodies can be
immobilized on the MC surface to detect potential EDCs.

2.1 Introduction
EDCs can adversely affect the health of human, domestic, and wildlife species by
altering or inhibiting the function of the endocrine system (65). Due to the extremely
wide range of biological processes EDCs can influence, often impairing, it is crucial to
screen and detect for them. EDCs include a wide range of naturally occurring and
synthetic chemicals. These chemicals and/or their byproducts include but are not limited
to pesticides, plasticizers, detergents, pharmaceuticals, and biological compounds
excreted by animals and plants (62, 63). Their interaction with hormone receptors, like
estrogen receptors, often disrupt the normal function of the receptor causing chronic,
debilitating health problems and disease (40, 58, 65).

These contaminants cause

undesirable effects to the endocrine system by mimicking or inhibiting a natural hormone
(65). The Endocrine Disruption Screening Program of the Environmental Protection
Agency (EPA) has mandated the screening and testing of chemicals to identify potential
EDCs and their toxicity, then determine and manage the risk associated with the
compound (65).

It is crucial to identify and manage potential EDCs in their

environments, so appropriate action can be taken to lessen or eliminate their effects.
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The screening of potential EDC candidates and the monitoring of known ones, as
well as mechanistic studies of endocrine processes, requires modern sophisticated
analysis methods and innovative, integrated instrumentation. Traditionally, the endpoints
used to determine these chemicals and their effects involve relatively complicated
bioassays (competitive binding assays, cell growth assays, and cell- based reporter
assays) that are time consuming to perform and include the use of complex biological
systems (40, 58, 87). More recently, simpler, non-label sensing methods to monitor
protein receptor-EDC interactions have been reported that employ surface plasmon
resonance and quartz crystal microbalance techniques (88-90). Relevant to this report,
biosensing applications have benefited in recent years from the attributes of modern
microelectromechanical systems (BioMEMS) (91).

Prominent among MEMS

approaches are nanomechanical methods based on microcantilever (MC) transducers.
The high sensitivity and widespread availability of inexpensive MCs have generated
intense interest in their use as chemical (17, 92, 93) and biological sensors (18, 21, 50,
56, 94). Additionally, MCs can be used with on-chip circuitry and in microcantilever
arrays (MCAs) for high throughput, simultaneous differential assays with a very small
sensor footprint that potentially can be employed in the field, advantages not fully
realized with more traditional sensors.
As discussed in Chapter 1, a MC suitable for biosensing is modified on one side
with a suitable receptor phase that has some degree of affinity for the analyte. Specific
interactions of the target analytes with that phase cause an apparent surface stress and
nanomechanical bending of the MC. The bending may be conveniently monitored using
the beam bending technique commonly used in atomic force microscopy. The static
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bending (tip deflection, zmax) of the MC varies in selectivity and sensitivity due to
preferential binding of analyte molecules on the functionalized, active MC surface and is
governed by Stoney’s equation (14). See equation 4 in Chapter 1.
We demonstrate that detection and screening for EDCs can be accomplished with
bioreceptor functionalized MCs.

These sensors provide real-time measurements of

surface stress changes in the low-to-sub-nanomolar range (50). By exploiting the protein
receptor-EDC interaction, as well as antibody-antigen/hapten reactions, we are able to
screen for potential EDCs and target specific compounds quickly and without extensive,
time-consuming labeling techniques (40, 62, 87).

Immobilization of EDC receptor

proteins on MCs with a non-specific orientation glutaraldehyde protocol does not appear
to appreciably denature the protein or otherwise inhibit interactions with known EDCs
and, moreover, allows for sufficient surface stress for sensitive detection. The sensitivity
and reversibility afforded by MCs with nanostructured active surfaces, as well as the
biological interaction, allows impressive limits of detection (LOD) in this work down to
~1x10-11 M, though the thickness of the nanostructured MC surfaces are not optimized in
this work (see figures in the Appendix). The EDCs studied herein include various
steroids, a plastic component, a synthetic estrogen, and the heavy metal cadmium.
Versatile screening of EDCs is accomplished by estrogen receptor-α (ER-α) and estrogen
receptor-β (ER-β) protein receptor-based MC systems, which can respond to a variety of
EDCs. Conversely, it is demonstrated that a specific estrogenic compound (17-βestradiol) can be targeted by antibody mediated nanomechanics. To our knowledge, this
is the first time estrogen responding receptors have been immobilized on a MC surface
for nanomechanical-based sensing.
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2.2 Experimental
Experiments were performed using commercially available silicon arrays of MCs
having dimensions 400 µm length, 100 µm width, and approximately 1 µm thickness
(Mikro Masch Co., Sunnyvale, CA). Chromium, gold, and silver metals deposited on the
MCs were obtained from Kurt J. Lesker, Gatewest, and Alfa Aesar Co., respectively, at
99.9% purity. 2-Aminoethanethiolhydrochloride (AET), glutaraldehyde (GA), the salts
employed for the preparation of buffer solutions, cadmium chloride, and all other
reagents were purchased from Sigma-Aldrich Chemical Co (St. Louis, MO) or Fisher at
highest available purity and used as received. The EDCs, diethylstilbestrol (DES), 17-βestradiol (17-β-ES or beta-ES or β-ES), 17-α-estradiol (17-α-ES or alfa-ES or α-ES),
bisphenol A (Bis A), androstenedione, p,p’-dichlorodiphenyldichloroethylene (p,p'-DDE)
and protein bovine serum albumin (BSA) were also obtained from Sigma-Aldrich. In
addition, 2-OH-estrone was obtained from Steraloids Inc. (Wilton, NH, USA).
Monoclonal anti-17-β-estradiol antibody (17-β-ES Ab) (mouse generated to a BSA
conjugate of the hapten) was purchased from Biogenesis, Inc. (Kingston, NH, USA).
Human recombinant ER-α and ER-β were purchased from Invitrogen Corp. (Carlsbad,
CA, USA). Water used to prepare solutions was obtained from a Branstead E-pure water
filtration system.
The process of creating nanostructured surfaces on MCs is described in detail
elsewhere (49). The cantilevers were first cleaned in a piranha bath (75% H2SO4, 25%
H2O2) for 30 minutes, followed by thorough rinsing in deionized water [Caution: piranha
solution reacts violently with organics]. The MCs were then placed into a physical vapor
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deposition (PVD) chamber (Cooke Vacuum Products, Model CVE 301, South Norwalk,
CT) to be coated on one side with the appropriate metallic films using thermal deposition.
To create a nanostructured MC, a thin film (~5nm) of chromium was applied to the
surface to act as an adhesion layer followed by a thin film of gold (~15nm). Next, a film
consisting of gold and silver was co-deposited. Subsequently, the silver was chemically
removed via oxidation from the film (“dealloying”) using an aqueous solution of 5
mg/mL HAuCl4 leaving a gold surface with nanosized, colloid-like features. The
thickness of the dealloyed gold layer was ~50 nm in these studies.
In these studies, nanostructured MCs were chemically modified by immersion in
1 mM aqueous solution of AET (16 hours) producing a self-assembled monolayer of
AET on the cantilever surface. Following thorough rinsing in deionized water, the amino
groups were derivatized with the cross linker by immersing the cantilever in a 2% (w/v)
solution of GA in water for 3 hours (95). The chemically treated cantilever was allowed
to soak in a large volume of water for a few minutes to remove any nonspecifically bound
GA on the nanostructured and silicon sides of the cantilevers.

Subsequently,

immobilization of both the estrogen receptor proteins (α and β) and 17-β-ES Ab was
achieved in random orientation by dipping the functionalized cantilevers into 100 mg/L
solutions of proteins or antibody in phosphate buffered saline (PBS, 10 mM, pH=7) for 4
hours. During functionalization with ER-α and ER-β, the MCs dipped into the protein
samples were kept at 4°C to maintain the ER activity. Both estrogen receptor proteins (α
and β) and antibodies were separately immobilized on the functionalized surfaces of
different cantilevers from separate arrays. After washing with PBS, the functionalized
microcantilevers could be stored in PBS at 4°C until it is used. Although we used an
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array of MC, in this study we chemically treated all the cantilevers the same and simply
recorded the response of a single randomly chosen MC within an array.
The MC deflection measurements were carried out using the optical beamdeflection technique as depicted in Fig. 8A. The apparatus included a 5 mW diode laser
(Coherent Laser Corp., Auburn, CA) operating at 632 nm, a spatial filtering and focusing
system, and an in-house built position sensitive optical detector. The output of the
detector was displayed and recorded using a SRS 850 DSP lock-in amplifier as a
multichannel digital recorder (Stanford Research Systems, Sunnyvale, CA). The signal
output is recorded as volts (approximately 1 nm zmax per mV output). Data was collected
at 1 Hz and then a moving averaging algorithm covering 180 data points was used to
generate the figures presented herein. This smoothing did not alter the shape of the true
response curves (92).
The cantilever system was mounted inside a ~5 µL volume flow cell made of a 3
cm diameter by 2 cm long Delrin rod that was machined with 1/16 inch diameter input
and output holes that meet at 1 cm distance apart at the face of the rod. Narrow bore
tubing of 1/16 inch O.D. was slid into the holes up to the rod face and secured with
fittings. A semi transparent silicone gasket, which is slightly thicker than the MC chip
(~500 µm versus 400 µm), was cut with a scalpel tool to form a ~250 µm wide flow
channel between the input/output holes and to tightly hold the MC chip (Fig. 8B). The
silicone gasket is sandwiched between the Delrin rod face and a thin quartz window. A
Watec CCD camera (Edmund Industrial Optics, Barrington, NJ) was used to image the
MC chip in the flow cell. The camera facilitated aligning the focused laser beam to
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Fig. 8. (A) Micrograph of silicon cantilevers (100 mm x 400 mm x ~1 µm thick) (a

linear 16 cantilever array was used in this work). Schematic depiction of the optical
detection system and surface-immobilized receptor proteins and antibodies (Y
symbols) are included in the figure. (B) Photograph of the delrin flow cell showing the
silicone gasket that defines a 250 mm flow channel and holds the MC chip.
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reflect off the cantilever tip. Analyte solutions were delivered to the flow cell via a
system of vessels connected to three-way valves allowing for switching between different
solutions. The gravity-driven flow was generally adjusted to 30 µL/minute by adjusting
vessel height.
Most of the EDCs are sparingly soluble in water. Thus, 1×10-2M stock solutions
of all EDCs were prepared in pure methanol and then diluted with PBS (10 mM
Phosphate Buffer + 10 mM NaNO3, pH = 7.0) to make the desired concentration of each
EDC [Caution: because of their potential harmful effects, care must be taken in the
handling and disposing of EDC solutions]. PBS was also used as a background solution.
MCs mounted in the flow cell were initially allowed to equilibrate in PBS until the signal
was stable. For our purposes, tensile and compressive responses involve contraction and
expansion of the active MC surface, respectively.

2.3 Results and Discussion
Our work addresses three analysis scenarios. Since hundreds to thousands of
potential EDC candidates have been targeted, and the effects of these candidates may be
seen in various mixed combinations, there is a pressing need for high throughput EDC
screening methods. Because a large number of EDCs exert their effects through estrogen
receptor (ER) proteins (97), our studies have focused on the development of MC systems
using these proteins as bioreceptor phases to screen for estrogenic compounds. A second
scenario involves the targeted detection of known EDCs in environmental samples such
as waste treatment streams, feed stocks, etc. wherein target specific bioreceptor phases
can be employed.

We use cantilevers modified with anti-17-β-ES antibody to
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demonstrate the potential utility of MC sensing in this situation. Finally, in comparison
to existing methods, we are developing MC systems that may prove to be a quicker,
simpler, and less expensive means to detect EDC actions in support of fundamental
endocrinology studies.
The promise of our nanomechanical approaches will depend largely on whether
adequate levels of sensitivity are reached for EDCs, since they are known to show effects
at extremely low concentrations. We have achieved substantial improvements in
sensitivity by nanostructuring the active surfaces of MCs by the described dealloying
process. In many cases the response enhancement has surpassed the increase in surface
area of the active surface (5, 17, 49). The enhancement in bioaffinity response with
nanostructuring is discussed and illustrated in the Appendix (see Fig. Appendix-1 and -2).
Conformational changes of MC surface immobilized proteins after binding with
analytes may give rise to relatively large cantilever responses (21, 50).

Since

conformational changes in the ligand binding region of ER proteins give rise to changes
in the DNA binding region of the proteins, this system is a good candidate for MC
nanomechanical sensing. However, there can be concern that chemical attachment to the
MC surface will make binding sites inaccessible or distort the sites such that the natural
affinity for ligands will be substantially altered. The results presented below provide
strong evidence that at least an appreciable fraction of the immobilized bioreceptors
remain active to ligand binding. It is important to note that unlike spectroscopic or
simple mass responding sensors, the MC sensor requires transfer of the energy of ligand
binding into surface stress. Thus, in the case of the ER proteins, immobilization at the
DNA binding sites which change configuration in response to conformation changes in
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the ligand binding region, may be desirable. It has been observed that proper orientation
of the bioreceptor proteins on the MC surface does not always yield improvements in
response (See Table Appendix -1), presumably because of the stress induction response
requirement.
Fig. 9A shows the comparison of nanomechanical responses of an ER-β
functionalized MC on exposure to 1×10-7M solutions of six different potential EDCs in
PBS, illustrating the selective interaction of DES and estradiols over the other EDCs.
The relatively slow response kinetics is consistent with prior protein bioreceptor MC
work (14, 15) and indicates that the small EDC molecule causes conformational changes
in the ER-β (see above) which translates into a large apparent surface stress on the
cantilever. The very high binding affinity of ER-β protein for DES followed by 17-β-ES
and 17-α-ES have been observed by other researchers (40, 97). Also, we have observed
the similar trend in the value of response magnitude for both 1×10-7 M and 1×10-9 M
solutions of these three EDCs. The binding affinity for Bis A is much lower than that of
ES (both α and β) and the very low binding affinity for p,p'-DDE and androstenedione
are in agreement with previous studies (40, 88, 97). The inset demonstrated the response
behavior of ER-β functionalized MC as a function of time for 1×10-7M of DES and Bis
A. An exposure time of 10 minutes produced a compressive surface stress (expansion of
the active surface) for both the EDCs that reverse when the analyte solution was replaced
by background buffer (PBS) solution. The relative magnitude of responses are consistent
with prior reports (88-90). In our previous studies, the reversible compressive response is
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Fig. 9. (A) Comparison of nanomechanical responses of ER-β functionalized MC on
exposure to 1x10-7 M and 1x10-9 M of several different potential EDCs in PBS
illustrating selectivity. The error bar indicates the standard deviation (with CV = 10
%) for three replicate measurements with three different MC arrays functionalized
with ER-β at different times using 1x10-7 M of different EDCs. The inset in (A)
provides representative time traces of ER-β functionalized MC on exposure to 1x107

M of two of the EDC analytes, DES and Bis A (arrows denote points of EDC and

PBS background in flow cell). (B) Comparison of ER-β to BSA (blank)
functionalized MC on exposure to 1x10-7 M of 17-β -ES in PBS.
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also observed for other bioreceptor functionalized dealloyed surfaces whereas similarly
functionalized smooth gold MC shows an irreversible compressive response on exposure
to the same concentration of analytes (21, 50) (also, see related discussion and Fig.
Appendix-1).
Fig. 9B compares the response of specific protein (ER-β) functionalized MC to
nonspecific protein (BSA) functionalized MC (blank) on exposure to the same
concentration (1×10-7 M) of 17-β-ES. A large compressive response was observed due to
the binding of 17-β-ES with a MC modified with ER-β protein whereas no response was
observed when the same analyte was exposed to the nonbinding protein (BSA)
immobilized MC. The fact that our MC system’s relative response magnitudes are
similar to prior works, and does not show a nonspecific blank response, is critically
important and indicates the surface immobilization of the ER-β does not substantially
alter its EDC ligand binding function and selectivity. However, it can not be assumed
that the surface immobilized receptors will retain the same ligand binding affinity
constants as observed in free form.
Studies have shown that there are a number of functional similarities between
human ER-α and ER-β, especially in the DNA binding domain (98). However, there are
also significant structural differences noted for human ER-α and ER-β and some of the
EDCs have differential binding affinity for human ER-α and ER-β (40, 88, 97). Fig. 10A
compares the nanomechanical responses of ER-α against ER-β functionalized MCs on
exposure to 1×10-9M of three test EDCs, 2-OH-estrone, 17-α-ES, and 17-β-ES. The
results in Fig. 10A show that 17-β-ES produce comparable responses with both ER
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Fig. 10. (A) Comparison of nanomechanical responses of ER-α and ER-β

functionalized MCs on exposure to 1x10-9 M of 2-OH-estrone, 17-α-ES, and 17−β-ES
in PBS. The error bar indicates the standard deviation (with CV = 8 %) for three
replicate measurements with three different MC arrays functionalized with ER-β at
different times using 1x10-9 M of different EDCs. (B) Response of ER-β
functionalized MC to 1x10-9 M of 17−β-ES; (a) absence and (b) presence of 1x10-8 M
of CdCl2.
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proteins indicating that it binds with equal relative affinity to both ER subtypes, which
was also observed before (40, 97). The other two EDCs, 2-OH-estrone and 17-α-ES
preferentially bind with ER-α producing 2-3 fold greater responses than with ER-β.
Greater binding for these EDCs with ER-α than ER-β was also noted by others in a prior
report, although by a greater factor than in our work (40). The optical systems used in
our prior reports on MC arrays, that were differentially coated with non-bioaffinity
receptor phases and optically probed, should transfer well to arrays employing different
protein receptor phases for simultaneous multi-bioaffinity measurements based on MCA
nanomechanics (99).
Previous studies have shown that heavy metal cadmium activates ER-α through
an interaction with the hormone binding domain of the receptor, thereby inhibiting
estradiol binding to the receptor (58).

Mechanistic studies of hormone agonist or

antagonist actions are vital for understanding and controlling the impacts of EDCs in the
environment. To demonstrate the potential of the MC nanomechanical sensor in such
studies, we sought to determine whether cadmium may also block estradiol binding to
ER-β. The response was recorded for a ER-β functionalized MC on exposure to 1×10-9M
of 17-β-ES in absence and in presence of 1×10-8M of CdCl2 (Fig. 10B). Initially, in
absence of cadmium ion, estradiol showed appreciable compressive response which is
reversed upon flushing the cell with background buffer. Subsequently, the same MC
upon exposure to 1×10-8 M of CdCl2 for 14 minutes produced a large compressive
response, most likely indicating the binding of cadmium ion with ER-β protein. Martin
and coworkers have shown that the interaction of cadmium with ER-α appears to involve
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several amino acids present in the hormone-binding pocket of the receptor, suggesting
that the metal may form a coordination complex with the hormone-binding domain (58).
Also, it is known that cadmium binds to ER-α with an affinity similar to that of estradiol
for the receptor. An injection of 1×10-9M of 17-β-ES for 10 minutes in presence of
CdCl2 showed no additional compressive response (Fig. 10B), which provides evidence
that the metal ion may also inhibit the binding of 17-β-ES to ER-β protein.
High levels of specificity involving molecular recognition, e.g., antibodyantigen/hapten interactions are generally considered desirable in analytical chemistry.
However, inherent to this high level specificity can be a lack of versatility and
reversibility. Herein, we have developed a MC based immunosensor using a monoclonal
antibody for 17-β-ES for selective and sensitive detection of 17-β-ES in presence of other
nonspecific analytes. 17-β-ES has no immunogenicity due to its small molecular size,
but antibodies generated to a BSA conjugate are commercially available and we have
functionalized dealloyed MCs using this antibody. In our prior work, glutaraldehydebased immobilization resulted in a cantilever resonance frequency decrease of
approximately 30 Hz, indicating less than a femtomole of antibody was immobilized on
the functionalized surface of a single MC (21).
Fig. 11 shows the cantilever response as a function of time when exposed to
1×10-8M of 17-β-ES in PBS. The specific interaction of the immobilized antibody with
17-β-ES resulted in a 60 mV compressive response (positive voltage signal), which is
likely to occur in similar fashion to the endocrine receptor protein case; i.e. a combined
effect of hydrogen bonding and hydrophobic interactions with the hapten cause
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Fig. 11. Nanomechanical responses of an anti-17-β-ES antibody (Ab) functionalized

MC to 1x10-8 M of 17-β-ES in comparison no responses to non-specific analytes 17α-ES and BSA at higher concentration of 1x10-7 M.
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rearrangement of the conformation of the large antibody biomolecule and an apparent
surface stress. It is interesting to see that the response increases even after injection of
background buffer which may involve the gradual conformational changes of the
antibodies to achieve a more stable conformation or wash out issues with our flow cell.
Also, it is interesting to observe that the nanomechanical response of the cantilever
produced by the antibody-hapten interaction on the nanostructured surface was easily
reversed with the replacement of the 17-β-ES solution by the background buffer (PBS)
solution despite the expected very large affinity constants (see “Response characteristics
of nanostructured MCs” in the Appendix).

In our previous studies (50), we have

observed the similar behavior; i.e. antibody functionalized nanostructured surface of MCs
are more easily regenerated than similarly functionalized smooth gold surface of MCs.
Irreversible response of the smooth gold surface was also observed by other researchers
for specific interactions of different antibody-antigen pairs (18, 56, 100). To check for
specificity, the same MC was again exposed to one order of magnitude higher
concentration (1×10-7M) of BSA (Ab was generated to BSA-hapten conjugate) and 17-αES, producing negligible deflection for each potential interferent.
Fig. 12A demonstrates nanomechanical response profiles of ER-β protein
functionalized MC to different concentrations of 17-β-ES in the range of 50 pM to 10 nM
where the response increases with increasing concentration. The kinetic response of the
cantilever after 4 minutes of exposure is plotted against the concentration of 17-β-ES
ranging from 50 pM to 100 nM in Fig. 12B. As seen in the figure, the response increased
gradually and reached a plateau by 100 nM. The inset in Fig. 12B illustrates a linear
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Fig. 12. Concentration based nanomechanical responses of (A) ER-β protein and (C)

anti-17-β-ES Ab functionalized MC to different concentrations of 17-β-ES.

Net

responses to 17-β-ES after 4 minutes and 10 minutes for ER-β protein and anti-17-βES Ab, respectively, functionalized MCs are plotted (B & D) over a concentration
range from less than 1x10-10 M (see lowest concentrations in A & C) to 1x10-7 M. The
linear portions of these plots extend over two orders of magnitude in concentration
(see inserts in B & D). The first data points in insert B and D correspond to 5x10-11 M
and 1x10-11 M of 17-β-ES respectively.
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dynamic range for more than two orders of magnitude (the first data point corresponds to
the lowest concentration of Fig. 12B) in concentration from an approximate LOD less
than 50 pM to 10 nM). Similarly, Fig. 12C shows the response profiles of an anti-17-βES antibody functionalized cantilever for different concentrations of 17-β-ES in PBS in
the range of 1 pM (approximate LOD is somewhat less than this) to 10 nM. The kinetic
response of the cantilever after 10 minutes exposure of the antibody functionalized MC is
plotted against the antigen concentrations over a range of 1 pM to 100 nM (Fig. 12D).
Our current experiment involving optimization of the thickness of the dealloyed surface
of the MC may improve the LOD lower than pM level (see the Appendix and Fig.
Appendix-2).
Prior work showed that calibration plots are generally linear for two or more
orders of magnitude, while coefficients of variation (CVs) for measurements using a
given system of MC and molecular-recognition phase are generally 10% or better (17, 21,
50, 92). Our experiments in the detection of 17-β-ES using both the receptor protein
(ER-β) and antibody (anti-17-β-ES Ab) showed good measurement reproducibility in the
same day tested via three replicate consecutive measurements of a solution of 1×10-10M
of 17-β-ES (see Fig. 13). ER-β functionalized MC arrays prepared in different batches
showed 8-10% CV values in the detection of different concentrations of 17-β- ES.
To investigate stability, anti-17-β-ES Ab functionalized MC was exposed to
1×10-9M of 17-β-ES at three different periods after storing in PBS at 4°C (2-nd, 4-th,
and 8-th day after functionalization), an average value of deflection on day 4 and day
8 were 97% and 76% of the initial response, respectively. Similarly, the stability of
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ER-β functionalized MC was studied over periods of 5 days after storing in PBS at
4°C wherein it showed poorer stability; exposure to 1×10-9M of 17-β-ES yielded
responses after 3 and 5 days that were 78% and 36% of the initial response,
respectively. Also, the stability of ER-functionalized MC was tested at 4°C varying
the environment (stored dry versus in PBS). The results showed that the immobilized
antibody retained it’s functionality for a longer period of time (7-10 days after
functionalization) if stored dry at 4°C whereas it can be stored in PBS for near
immediate use. Surprisingly, in both of the experiments performed, the response
actually increased by a factor of two after one week of dry storage at 4°C.

2.3 Conclusions
In summary, a highly sensitive, biospecific, and reusable biosensor for the
detection and screening of EDCs has been developed using nanostructured MCs by
exploiting protein receptor-EDC and antibody-EDC interactions. Our results indicate
that the interaction of ER protein with different ligands produced different cantilever
responses showing the maximum response for the synthetic estrogen DES with the ER-β
functionalized MCs followed by estradiols and other EDCs. While receptor proteins
provide generalized responses to subclasses of EDCs with impressive LODs, antibodies
specific to a particular EDC can be used for specific analyte detection with a linear
dynamic range over two orders of magnitude in concentration and about 3% of intra-day
RSD. Also, measurements exhibited 10% RSD between different MC arrays
functionalized at different times.
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Since a single analyte ligand can stimulate changes in multiple receptor proteins
and thereby synergistically mediate diverse biochemistry in complex living systems, an
integrated analysis tool in a small, inexpensive platform is highly desirable. Thus, future
research will involve the development of efficient and reproducible methods to
differentially functionalize the cantilevers in arrays with different types of receptor
proteins, the resulting chip platforms are expected to provide unique capabilities and
exhibit significant biomedical and environmental utility.
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Chapter 3 Morphological and Chemical
Optimization of Microcantilever Surfaces for
Thyroid System Biosensing and Beyond
Chapter 3 is an adaptation of a research article Analytica Chimica Acta 2008, 625,
55-62. In this article protein immobilization conditions were optimized, which includes
the gold nanostructured surface, aminoethanethiol and glutaraldehyde conditions, and
protein incubation conditions. These optimized conditions were applied to thyroid
transport protein functionalization to detect and screen for thyroid disrupting chemicals.

3.1 Introduction
Biomedical, environmental, and many other areas of research rely on biosensors
for screening and detecting environmental contaminants that can have detrimental health
effects on humans, livestock, and wildlife. The development and optimization of a labelfree biosensor based on ligand-induced nanomechanical responses of microcantilevers
(MCs) allows for sensitive and selective detection of contaminants from their specific
interactions with the biomolecular recognition phase immobilized on the active surface of
the MC. Functionalizing only one side of the MC with some receptor phase allows one
to measure the static cantilever deflection due to molecular recognition events which
generate surface stress. The bare silicon side of the cantilever is relatively passive. This
active side binding causes a change in surface stress. The resulting static bending of the
MC is governed by Stoney’s equation (14). See equation 4 in Chapter 1. Due to the
small size of MCs (herein l = 400 µm and t ~1 µm), they exhibit high mass sensitivity
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compared to other types of sensors. The widespread availability of inexpensive MCs has
generated interest in these transducers as chemical (17, 93, 101-104) and biological (18,
21, 56, 105-111) sensors. Sensitivity is critical in these biosensors due to the ultra-trace
concentrations of many contaminants that impact biological systems. Nanostructured
MC biosensors allow detection without labels and in a detection range that is applicable
for real biological systems (112).
Three key performance metrics are generally significant in biosensing. First, the
specificity of the ligand-receptor interaction is important in achieving the selectivity
needed to deal with complex biological matrices and, second, high sensitivity is needed
to deal with the fact that ultra-trace concentrations of many ligands impact biological
systems. Finally, high selectivity and sensitivity must be achieved while maintaining the
reversibility that is a base requirement of any true sensor. For a more in depth discussion
of these performance metrics see Chapter 1. The nature of the MC surface and the
method by which the bioreceptor is immobilized influence these performance metrics
and, hence, optimization studies involving these were conducted.
In our previous studies (21, 50), we observed sensitive, reversible bionanomechanical responses with MCs that have the active side nanostructured via a
dealloying process. Dealloying is accomplished by co-depositing gold and silver onto the
MC surface, then removing the silver via oxidation leaving a roughened (granular or
porous) gold surface (49). In the initial dealloyed studies, the sensitivity and reversibility
was very good, particularly when compared to smooth gold MCs, so until recently we
had not fully optimized the dealloying surface treatment step. In this paper, we optimize
the dealloyed thickness and gold to silver ratio for a model biological system, anti57

immunoglobulin (anti-IgG)-IgG. The concentration, buffer pH, and incubation time of
the immobilization linking chemistry and protein or antibody functionalization conditions
were optimized by comparing model systems’ responses. By varying these conditions,
we demonstrate the reversibility and sensitivity of our bio-functionalized MC sensors and
clearly demonstrate the advantages of using nanostructured MCs.

Random versus

specific antibody/antigen immobilization experiments yield surprising results, which
illustrate the importance of optimizing immobilization methods and the unique response
characteristics of transducers that rely on the generation of surface stress.
We report for the first time the use of thyroxine binding globulin (TBG), a thyroid
transport protein, for sensing thyroid disrupting chemicals (TDCs) under non-optimal and
optimal immobilization conditions on MCs.

TDCs are a sub-class of endocrine

disrupting chemicals (EDCs), which include organohalogen compounds.

TDCs can

affect the thyroid hormone system at the thyroid gland, the thyroid transport proteins, and
the thyroid hormone metabolism (37). Disrupting thyroid activity can occur at different
levels and cause many adverse health problems. Traditionally, complex competitive
binding assays, like radioligand binding assays, and surface plasmon resonance based
inhibition assays have been used to detect TDCs (37, 69).

These methods require

extensive labeling or complex biological assays. Meerts et al. radioligand binding assay
method tested various potential TDCs with L-thyroxine (T4) binding to transthyretin
(TTR), a thyroid transport protein, down to 1.95 nM concentration of TDCs (37). The
sensitivity of the surface plasmon resonance based inhibition assay of Marchesini et al.
with TBG for T4 is 0.7 nM (69). Mikami et al. detected T4 in dietary supplements with
absorbance based ELISA and liquid chromatography-mass chromatography (LC/MS).
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The LC/MS detection had a lower limit of detection, which was approximately 0.64 µM,
than the ELISA method (33). Although not T4 detection, Kerrigan et al compared two
types of enzyme-linked immunosorbent assay (ELISA) kits in detecting drugs of abuse,
where the lower detection limit is approximately <3.2 nM (32). We optimize a label-free
TDC nanomechanical biosensor used to screen various TDCs that shows excellent
sensitivity, down to 0.1 nM, and reversibility for the main hormone of the thyroid system,
T4. Selectivity patterns in this TDC work (see below) and in prior EDC work (15) are
consistent with that appearing in the literature. Thus, the three performance metrics are
addressed in this application with optimized MC biosensors providing high selectivity,
sensitivity, and reversibility.

3.2 Experimental
Experiments were performed using commercially available silicon arrays of MCs
having dimensions 400 µm length, 100 µm width, and approximately 1 µm thickness
(Mikro Masch Co., Sunnyvale, CA). Chromium, gold, and silver metals deposited on the
MCs were obtained from Kurt J. Lesker, Gatewest, and Alfa Aesar Co., respectively, at
99.9% purity.

2-Aminoethanethiolhydrochloride (AET), 4-aminothiophenol (ATP),

glutaraldehyde (GA), the salts employed for the preparation of buffer solutions and all
other reagents were purchased from Sigma-Aldrich Chemical Co (St. Louis, MO) or
Fisher at highest available purity and used as received.

The proteins human

immunoglobulin G (hIgG, reagent grade), anti-hIgG (Fc specific) antibody produced in
goat (anti-hIgG Ab), TBG from human plasma, L-thyroxin, biotin A, anti-biotin antibody
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produced in goat, and Protein A were also obtained from Sigma-Aldrich. Water used to
prepare solutions was obtained from a Branstead E-pure water filtration system.
The process of creating nanostructured surfaces on MCs is described in detail
elsewhere (49). The cantilevers were first cleaned in a piranha bath (75% H2SO4, 25%
H2O2) for 30 minutes, followed by thorough rinsing in deionized water [Caution: piranha
solution reacts violently with organics]. The MCs were then placed into a physical vapor
deposition (PVD) chamber (Cooke Vacuum Products, Model CVE 301, South Norwalk,
CT) to be coated on one side with the appropriate metallic films using thermal deposition.
To create a nanostructured MC, a thin film (5 to 10 nm) of chromium was applied to the
surface to act as an adhesion layer followed by a thin film of gold (~15 nm). Next, gold
and silver were co-deposited to the desired film thickness. In most cases the deposition
rates for the two metals were set to create a 50:50 alloy, but in this study 40:60 and 60:40
ratios were also tested for effects on MC performance. The deposition rate and film
thickness were monitored using a quartz crystal microbalance. Subsequently, the silver
was chemically removed via oxidation from the film (dealloying) with an aqueous
solution of 5 mg/mL HAuCl4 leaving a gold surface with nano-sized, colloid-like
features. The thickness of the dealloyed gold layer was varied from 25 to 200 nm, but it
was ~150 nm in most of these studies.
In these studies, nanostructured MCs were chemically modified by immersion in
aqueous solution of AET, or in one study ATP, (concentration and time of incubation
with the thiol compounds were varied to get the optimum kinetic response of the protein
functionalized MC) producing a self-assembled monolayer (SAM) of AET/ATP on the
cantilever surface. Following thorough rinsing in deionized water, the amino groups
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were derivatized with the cross linker by immersing the cantilever in a solution of GA
(95) where concentration and pH of the GA solution as well as the time of incubation
were varied to optimize the conditions of functionalization. The chemically treated
cantilever was allowed to soak in a large volume of water/phosphate buffered saline (10
mM pH 8 PBS) for a few minutes to remove any nonspecifically bound GA on the
nanostructured and silicon sides of the cantilevers. Subsequently, immobilization of antihIgG Ab in random orientation was optimized by dipping the pre-functionalized
cantilevers into different concentrations of antibody solutions in PBS varying the
incubation time. For the orientation studies, 0.5 mg/mL of hIgG antigen (Ag) or antihIgG antibody (Ab) was immobilized directly on the functionalized dealloyed surface of
the cantilevers. The MCs were functionalized by 1mM AET (1 hour incubation) and 1%
GA (3 hours incubation). The Ag or Ab was immobilized for an hour. Immobilization of
Ab and Ag (0.5 mg/mL) anchored in oriented manner was performed by immersing AETGA pre-functionalized microcantilevers (optimized conditions) in 0.5 mg/mL protein A
solution in 10 mM pH 7 PBS for one hour and then functionalized with Ag or Ab in the
same manner mentioned above.

After washing with PBS, the functionalized

microcantilevers are stored in PBS at 4°C until it is used or until the next day for the best
performance. Although we used a MC array in this study, we chemically treated the
array and recorded the response of a single randomly chosen MC.
The MC deflection measurements were carried out using the optical beamdeflection technique as described previously (17). The apparatus included a 5 mW diode
laser (Coherent Laser Corp., Auburn, CA) operating at 635 nm, a spatial filtering and
focusing system, and an in-house built position sensitive optical detector (Fig. 2). The
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whole microcantilever sensor system was mounted on vibration-free High Performance
Table Top (Newport Corp., CA). The output of the detector was displayed and recorded
using a SRS 850 DSP lock-in amplifier as a multichannel digital recorder (Stanford
Research Systems, Sunnyvale, CA). The signal output is recorded as volts (approximately
1 nm zmax per mV output). Data was collected at 1 Hz and then a moving averaging
algorithm usually covering 32 data points was used to generate the figures presented
herein. This smoothing did not alter the shape of the true response curves (92).
The MC system was mounted inside a ~5µL volume flow cell made of a 2 cm
diameter by 2 cm long Delrin rod that was machined with 1/16 inch diameter input and
output holes that meet at 1 cm distance apart at the face of the rod (15). Narrow bore
tubing of 1/16 inch O.D. was slid into the holes up to the rod face and secured with
fittings. A semi transparent silicone gasket, which is slightly thicker than the MC chip
(~500 µm versus 400 µm), was cut with a scalpel tool to form a ~250 µm wide flow
channel between the input/output holes and to tightly hold the MC chip. The silicone
gasket is sandwiched between the Delrin rod face and a thin quartz window. A Watec
CCD camera was used to image the MC chip in the flow cell (Fig. 8). The camera
facilitated aligning the focused laser beam to reflect off the cantilever tip (Edmund
Industrial Optics, Barrington, NJ). Analyte solutions were delivered to the flow cell via a
system of vessels connected to three-way valves allowing for switching between different
solutions or via an injection valve controlled by a syringe pump (orientation studies). The
flow rate was generally adjusted to 100 µL minute-1.
Solutions of hIgG were made with PBS (10 mM Phosphate Buffer + 10mM
NaNO3, pH 7). PBS was also used as a background solution. The pH of PBS solution was
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checked before experiments using an Orion SA 520 pH meter (Thermo Orion, Beverly,
MA). MCs mounted in the flow cell were initially allowed to equilibrate in PBS until the
signal was stable. For our purposes, tensile and compressive responses involve
contraction and expansion of the active MC surface, respectively.

3.3 Results and Discussion
Our work focuses on five optimization aspects for biofunctionalized MCs. The
optimized functionalization steps include dealloyed thickness and metal ratio, the
incubation time and concentration for AET, the buffer pH, concentration, and incubation
time for GA and two model proteins, and the orientation of proteins. We applied these
optimized conditions to TBG immobilization for detecting and screening TDCs and
thyroid hormones.

We compared the responses of TBG functionalized MCs under

optimal versus non-optimal biofunctionalization conditions.

Our developing MC

biosensors, in support of fundamental endocrinology studies, may prove to be a quicker,
simpler, and less expensive method to detect TDCs compared to existing methods.
Enhancement of sensitivity in biosensing is important due to the small
concentrations of ligands that often stimulate or impair receptor proteins.

We have

substantially improved the sensitivity of MC biosensors by nanostructuring the active
surfaces of the MC by the described dealloying process. In some cases the response
enhancement has surpassed the increase in surface area of the active surface (5, 17, 49).
The bioaffinity response was enhanced with previous nanostructured surface techniques,
but the current optimization allows for responses to be further enhanced.
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Fig. 14 shows the comparison of MC responses by varying the thickness of 50
gold :50 silver dealloyed surface with immobilized anti-hIgG exposed to 0.05 mg mL-1 of
hIgG in PBS. This figure demonstrates increased response with varying thicknesses with
the best enhancement afforded by 150 nm dealloyed. A trend is observed for greater
response with increasing dealloyed thickness until a drop in response when the thickness
reaches 200 nm. This trend may be a result of apparent increasing surface area. With the
increasing thickness and surface area, the ∆σ term in the Stoney equation (eq 4) is
expected to increase as well (92). While ∆σ is increasing, the stiffness due to changes in
the Young’s modulus and cantilever thickness (note Et2 in the denominator) is most
likely increasing with dealloyed thickness.

These two terms oppose one another

according to eq 4, resulting in an optimal dealloyed thickness for best MC performance
(Fig. 14). The inset in the figure shows three responses for immobilized anti-hIgG on 50
nm dealloyed on exposure to 0.05 mg/mL hIgG in PBS. The experiments do not reach
equilibrium because we purposefully inject analyte for a brief period of time. The time
scale of response is determined by the kinetics of the protein-analyte binding and that
interaction is translated to cantilever surface stress. Rearrangement of the immobilized
protein occurs when analyte molecules, which include antigen and small molecule
analyte solutions, interact with the protein. This relatively slow rearrangement leads to
MC surface stress. MC biosensor response time depends on factors such as the kinetics
of the protein interaction as well as the rearrangement of the immobilized protein upon
analyte binding. It is worth noting that operating in this non-equilibrium mode enhances
reversibility (see the figure).
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Fig. 14. Comparison of responses of anti-hIgG Ab functionalized DA MCs

with different thicknesses of the DA layers on exposure to 0.05 mg/mL of
hIgG in 10 mM pH 7 PBS. The error bar indicates the standard deviation (with
CV = 6.5%) for three replicate measurements with the same MC. The insert
provides three response profiles of anti-hIgG Ab functionalized MC on
exposure to 0.05 mg/mL hIgG for 50 nm thick DA (arrows denote points of
introducing hIgG solution and PBS background into the flow cell). Three
different composite ratios for gold and silver were compared for a 50 nm DA
layer which were functionalized with anti-hIgG Ab and exposed to 0.05
mg/mL hIgG.
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Fig. 14 also compares anti hIgG Ab functionalized 50 nm dealloyed MC
responses varying the gold to silver ratio, which comprises the dealloyed, with the latter
removed via oxidation with HAuCl4. Three different composites were studied (40:60, 50
:50, and 60 :40 gold : silver) with immobilized anti-hIgG subsequently exposed to hIgG.
The best response is observed from the 50:50 gold :silver system. This ratio appears to
allow for the optimal porosity of the gold when the silver is removed while maintaining a
stable metal surface.
Concern arises when immobilizing proteins that the chemical attachment of the
protein will cause the protein binding sites to distort or be blocked. This problem would
not allow the benefit of the natural antibody/antigen or hapten affinity binding. Our
previous studies have provided evidence that an appreciable portion of the protein
binding sites remain functional after immobilization (15, 20, 50). In this work, we
optimized the immobilization steps so that we obtain an enhanced bioaffinity response.
The initial linking chemistry step exposes the nanostructured dealloyed surface to
AET producing a self-assembled monolayer.

A comparison of AET and ATP was

performed. AET and ATP have similar terminal groups, but different carbon backbones
or structures. AET consists of a two carbon chain, whereas ATP has a rigid aromatic
ring.

The aromatic ring makes the molecule larger than AET, which could hinder

unwanted crosslinking with two adjacent GA groups. However, this did not prove to be
beneficial in terms of enhanced responses in this work. Fig. 15 compares bioaffinity
(anti-hIgG-hIgG) responses on 150 nm dealloyed by varying concentration and time of
incubation for AET.

The inset shows a representative trace of an anti-hIgG Ab

functionalized MC exposed to 0.05 mg/mL hIgG with a 1 hour incubation in a 1 mM
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Fig. 15. Nanomechanical responses of anti-hIgG Ab functionalized 150 nm DA

MCs on exposure to 0.05mg/mL hIgG in PBS. The concentration and time of
incubation with AET solution were varied. The insert shows a representative
response profile of anti-hIgG Ab immobilized on 150 nm DA MC exposed to 0.05
mg/mL hIgG with 1 mM AET (1 hour incubation) functionalization. The arrows
denote points of introducing hIgG solution and PBS background in the flow cell,
respectively.

67

AET solution. The best response was observed when conditions were 1 mM AET for 1
hour.

This also shows that AET achieves a better anti-hIgG-hIgG nanomechanical

response than ATP under the same conditions.
The amino groups from the AET were derivatized with a cross-linker by
immersing the MC in a GA solution. GA acts as a linker for the immobilized antibodies
or proteins to the surface. It is generally accepted that reactions between the carbonyl
group of GA and the amino functions of the protein take place yielding a Schiff base
(113). Terumichi et al. have previously reported that the activity of enzyme increased by
using alkaline-treated GA, suggesting alkaline treated GA may act as a crosslinker in a
manner different from the generally accepted Schiff base formation reaction (114). A
possible mechanism may involve the additional reaction of an amino group to the double
bond in the aldol condensate of GA (115). So, in these studies, GA was functionalized in
both pH 7 and pH 8 PBS varying the concentrations and time of incubation to compare
the responses of Ab functionalized MCs in different conditions. Antibodies and proteins
are not appreciably denatured by GA immobilization (56). Fig. 16 shows immobilized
anti-hIgG Ab responses upon exposure to 0.05 mg/mL hIgG with varying GA
concentration, pH, and incubation time. The optimal GA conditions are 1% GA in 10
mM 8 pH PBS for 3 hours. These optimized conditions are relatively minor changes
from our established conditions for AET and GA. A representative response profile for
the anti-hIgG-hIgG system is shown in the insert for MC treatment in 2% GA in 10 mM
pH 8 PBS with an incubation time of 3 hours.
experiments the AET was under optimal conditions.
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For all of the GA optimization
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Fig. 16. Comparison of responses of anti-hIgG Ab functionalized 150 nm

DA MCs on exposure to 0.05 mg/mL hIgG in PBS at different conditions of
GA functionalization. The concentration, pH and time of incubation with GA
solution were varied. The insert shows a representative trace of anti-hIgG Ab
immobilized on a 150 nm DA MC which was functionalized with a 2% GA
solution in 10 mM pH 8 PBS for 3 hours. The arrows denote points of
introducing hIgG solution and PBS background in the flow cell, respectively.
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Antibody-antigen interactions involving high specificity is a desirable
characteristic for biosensors.

Biofunctionalized MCs exploit this interaction often

resulting in high sensitivity and selectivity. The antibody has an inherent selectivity for
various antigens. Our prior work showed that calibration plots are generally linear for
two or more orders of magnitude, while coefficients of variation (CVs) for measurements
using a given system of MC and biological molecular-recognition phase are generally
10% or better (15, 21, 50). For endocrine disrupting chemical sensing, we have
demonstrated CVs of 2.4% and 3.1% for triplicate replicate consecutive intra-day
injections of 17-β-estradiol with estrogen receptor β and 17-β-estradiol antibody (15).
Our immunosensor for human interleukin-1 β (HILI-β) Ab on exposure to HILI-β
antigen showed a CV of 10% of triplet replicate intra day injections (50).

In

stereoselective detection, we have shown detection of chiral amino acids with antibody
immobilized MCs with excellent same day reproducibility (CV=2%) (9). Our previous
studies illustrate the reproducibility of the nanomechanical biosensor which we utilized
and optimized for these experiments. Biosensor problems can arise from a lack of
reversibility due to high affinity. We have developed a MC-based immunosensor that
allows the antibody-antigen interaction to be reversed with the replacement of antigen
with background buffer.

This reversibility on the nanostructured surface has been

observed in our previous work as well (15, 50).
To compare optimization conditions for protein immobilization we choose two
common model systems for study, anti-hIgG-hIgG and anti-biotin-biotin. hIgG is a
antibody with a molecular weight of approximately 150,000 Da, while biotin is
considered a small molecule (hapten) with a molecular weight of 244 g/mol (116). hIgG
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is the most common class of immunoglobulin and provides the majority of antibody
based immunity (69), while biotin is a common water soluble vitamin (116). These
systems were chosen due to their differences in size, low cost, and their common use in
biosensor applications.
Fig. 17 compares anti-biotin and anti-hIgG interaction when exposed to 0.05
mg/mL biotin or hIgG under various immobilized antibody concentrations and incubation
times. The best conditions for both anti-biotin and anti-hIgG were observed for 0.5
mg/mL protein solution for 1 hour on 150 nm dealloyed. When a protein is not readily
available at this high of a concentration, then a less concentrated solution can be used
with a longer incubation time, although depending on protein stability a shorter
incubation time may be required. The AET and GA were also under optimal conditions
for these protein optimization experiments. The inset shows a representative response
profile for the optimized conditions of 0.5 mg/mL anti-hIgG with a 1 hour incubation
time exposed to 0.05 mg/mL hIgG.
We also report receptor orientation studies using a MC sensor system. Earlier
work demonstrated that simple physical adsorption of protein on MCs did not provide
stable receptor phases and that some form of stronger attachment is needed (102, 103).
Thus, the covalent attachment of protein receptors via AET and GA chemistry was
pursued and optimized as described above. However, most proteins including hIgG
contain randomly distributed lysine residues which lead to multiple attachment sites,
resulting in random orientation on the surface (117). While stability is required and will
benefit from multiple points of attachment, distortion of the receptor can diminish ligandreceptor binding and thus effecting both sensitivity and selectivity. In addition, the
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Fig. 17. Comparsion of responses of anti-hIgG and anti-biotin functionalized
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biotin D in PBS. The concentration of protein and incubation time were varied.
The insert shows the response of 0.5 mg/mL anti-hIgG with a 1 hr incubation
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respectively.
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ligand receptor site can be surface confined and not available to the ligand. Fig. 18
provides a graphic depiction of a hIgG (Ag) and anti-hIgG (Ab) system with both species
used as the receptor in separate experiments, with the other protein acting as the ligand.
For this system the binding sites of the Ab resides in the two Fab portions and the Fc
portion of the Ag represents the epitope for the monoclonal Ab. The figure also depicts
the use of Protein A as an orientation linker that is specific for the Fc portion of the hIgG
molecule (Ab or Ag).
In Fig. 18A, randomly functionalized MCs with Ag gave 225 mV reversible
compressive stress responses on exposure to anti-hIgG (0.05 mg/mL) in 10 mM pH 7
PBS. Note that some of the surface immobilized Ag are depicted not properly oriented
with the Fc portion easily accessible to the Ab. When the Ag is properly oriented with
Protein A linkage the response increases to 420 mV (Fig. 18B), whereas when random
orientation is performed using immobilized Ab (Fig. 18C) and exposure to Ag, (0.05
mg/mL) in 10 mM pH 7 PBS, the response is less (115 mV) for the same Ab-Ag pair.
The most surprising result occurs when the Ab is properly oriented with Protein A (Fig.
18D) resulting in a minuscule 15 mV signal when exposed to the Ag. These results while
surprising, were repeatable, and in agreement with our previously obtained results under
non-optimized conditions (15), but are contrary to other reports (50, 111, 112). Factors to
consider are that the immobilized species is monovalent in the case of the Ag while
bivalent in the case of the Ab, such that each species may have specific preferred surface
binding sites. Nanomechanical responses are generated from surface stress and are not
strictly mass dependent. Although only a cartoon depiction we purposely show the
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Fig. 18. Left two pictures represent 0.5 mg/mL hIgG (Ag) immobilized in random

(A) (no protein A attached) and oriented (B) (0.5 mg/mL protein A) manner on 150
nm DA MCs. Right two pictures visualize 0.5 mg/mL anti-hIgG (Ab) immobilized
(functionalized) in random (C) (no protein A attached) and oriented (D) (0.5 mg/mL
protein A) manner on 150 nm DA MCs. Functionalized MCs were exposed for 10
min to 0.05 mg/mL anti-hIgG (Ab) – (A) and (B), and hIgG (Ag) – (C) and (D) in 10
mM pH 7 PBS, respectively. All voltage responses are average of two experiments.
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highest loading of surface for the system that generated the smallest response (Fig. 18D).
That is the case where minimal steric issues arise, but the smallest amount of ligand
binding energy is transferred to the surface of the MC (note the protein mass between the
surface and the binding site). Conversely, in the case of the largest signal (Fig. 18B) Ag
and Ab are competing for similar portions of the surface bound receptor (Protein A). It is
clear that optimal conditions are influenced by the nuances of the biosystem involved and
one should guard against over generalizations on the best methods for immobilization.
Applying these optimized nanomechanical sensing conditions to the real life
application of detecting TDCs should allow for enhanced sensitivity, which is crucial due
to the small concentrations of contaminants that can adversely affect the body. TDCs can
modulate the thyroid system leading to disturbances in hormone status and thyroid gland
processes. Screening for all potential TDCs or EDCs is a major challenge since the list of
known compounds is ever expanding. This marks the importance of the development of
a real-time, highly sensitive, label-free biosensor.
Fig. 19A illustrates the use of a TBG functionalized MC for the detection of four
compounds, which include potential TDCs and natural hormones. In human plasma,
TBG is the major thyroid transport protein for T4. It is responsible for 75% of the T4
binding activity. TTR, another thyroid transport protein in human plasma, carries ~20%
of T4 (69). TBG has a slightly higher binding affinity for T4 than TTR. TBG and TTR
may bind with different structural characteristics of the T4 molecule, which indicates
their unique T4 binding properties (41). Previous studies have shown that TBG and TTR
have different binding affinities with various environmental contaminants (41, 69, 118).
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of responses of TBG functionalized DA MCs on exposure to 1x10-6 M solutions of
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representative response profile for immobilized TBG exposed to T3. (B)
Concentration-based nanomechanical responses of TBG protein functionalized
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M.
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We choose to study TBG’s interaction with contaminants, as well as natural hormones.
Two naturally occurring hormones include T3 and T4, where T4 is the main hormone of
the human thyroid system.

T4 is also one of the top 200 most widely prescribed

pharmaceuticals in the United States, so it is present in the environment and inadvertent
exposure is possible, like many other pharmaceuticals, thus it is a potential TDC as well
(105). Comparison of nanomechanical responses of TBG functionalized MC on exposure
to 1 x 10-6 M solutions of four different potential TDCs in PBS is shown in the Fig. 19A.
This figure shows that TBG exhibits selectivity toward T4 compared to the other TDCs.
The high affinity of TBG for T4 followed by T3 then Bis A and TBrBis A has been
observed by other researchers (105).

This similarity demonstrates that the

immobilization of TBG does not significantly alter the TDC ligand binding function and
selectivity. The inset demonstrates the response behavior of TBG functionalized MC as a
function of time for exposure to 1 x 10-6 M T3. During the optimization study some of
the TDC experiments were performed under partially optimized conditions.
Fig. 19B compares the response of TBG functionalized MC to different
concentrations of T4. The net responses to T4 at 8 minutes time are plotted. A 4 hour
incubation time was used here due to the stability of TBG. The T4 concentration extends
over a range of 4 orders of magnitude with sub nanomolar sensitivity.

TBG

functionalized MCs under optimal conditions yielded over 400% more response than
non-optimized conditions.
In the present work, we have optimized a highly sensitive, label-free
nanomechanical biosensor and applied these optimized conditions to detect TDCs with a
thyroid transport protein. Optimizing the nanostructured surface, linking chemistry, and
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protein functionalization conditions demonstrates the reversibility and sensitivity of our
MC biosensors, which are critical aspects of any biosensor. The optimized sensors allow
for screening and detecting various contaminants that may adversely affect the thyroid
system. The protein immobilization process takes less than one day and our results
provide strong evidence that at least an appreciable fraction of protein ligand binding
sites remain active.

These two factors are important in creating nanomechanical

biosensors.
Further studies will apply these optimized conditions into creating differential
MCAs (i.e., multiple receptors on a single array) for biosensing. The development of
MCAs functionalized with multiple protein receptors is expected to have utility that
extends beyond simply being novel nanomechanical sensor arrays. Significant to the
differential MCA approach is the possible synergy between the effects of different small
molecules (drugs, pollutants, hormones) on the responses of different immobilized
receptors in determining holistic biomedical impacts. Thus, a novel bioassay tool that can
simultaneously probe many such systems in a small, low volume, inexpensive and
disposable platform is highly desirable and represents to a future direction of this work.
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Chapter 4 Microcantilever-based
Nanomechanical Studies of the Orphan Nuclear
Receptor PXR
4.1 Introduction
Humans are exposed to harmful chemicals and contaminants each day. It is
essential that these toxins are removed or detoxed from the body.

These foreign

compounds or xenobiotics, which include environmental toxins, endogenous hormones,
steroids, pharmaceuticals, and dietary supplements, trigger a line of defense mechanisms
within the body. The family of cytochrome P450 enzymes are the main xenobiotic
defenders for mammals.
monooxygenases:

These enzymes include four families of cytochrome P450

CYP1, CYP2, CYP3, and CYP4 (76).

Cytochrome P4503A4

(CYP3A4), a critical member of our defense system, makes the removal of many
unwanted xenobiotics possible (77). CYP3A4 and it’s isoforms are highly involved in
pharmaceutical metabolism, playing a significant role in metabolizing approximately
50% of drugs used today (84, 119). When xenobiotic ligands bind to a specific nuclear
hormone receptor, the interaction transcriptionally activates CYP3A4 (78). In 1998, a
novel orphan human nuclear receptor was identified and termed pregnane X receptor
(PXR), steroid and xenobiotic receptor (SXR), pregnane activated receptor (PAR), and
NR1I2 (72-75). Herein, we choose to use the term PXR.
PXR is an orphan nuclear receptor that displays broad ligand specificity and is
expressed mainly in the liver and intestine (82). Orphan receptors do not have specific
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identified hormones and can be utilized in the search for unknown hormones through
reverse endocrinology (77). PXR’s promiscuity makes it unlike most other types of
hormone receptors, which are highly selective to their specific hormone.

PXR is

activated by a broad array of structurally diverse xenobiotics (79). This wide activation
range is possible is due to a unique ligand binding domain (LBD) or pocket, which can
expand to fit a variety of sized ligands. PXR’s LBD has two β strands that are not
present in other nuclear receptors and that allow it’s expansion (80). This flexible,
hydrophobic LBD allows PXR to be activated by a diverse range of synthetic and
naturally occurring chemicals making it an ideal candidate to serve as a xenobiotic sensor
(82).
Importantly, PXR is activated by numerous pharmaceuticals with diverse
properties, functions, and structures and controls the expression of genes that are vital to
pharmaceutical metabolism (81, 83). PXR activation mediates transcription of CYP
enzymes, including CYP3A, and many other enzymes and transporters within the body
(82).

CYP enzymes are considered drug metabolizing enzymes (76).

Since, PXR

activation allows for regulation and expression of CYP3A this interaction is critical to
drug metabolism (77).

CYP3A processes drugs and endogenous chemicals through

oxidative, peroxidative, and reductive metabolism. CYP3A4 also oxidizes cholesterol to
4β-hydroxycholesterol, a major circulating oxysterol, which is important in many
biological processes (119). Pharmaceutical metabolism and interaction is vital to monitor
and prevent drug-drug interactions.

Drug-drug interactions can occur when co-

administered drugs alter the efficacy of one another. This usually occurs when one drug
increases or decreases the metabolism of another (84, 85). Contaminants could modify
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drug concentrations in vivo and skew the prescribed therapeutic dose. These cases could
lead to fatal consequences.
High throughput, sensitive screening and detection of xenobiotics are critical to
determine harmful toxins and possible drug-drug interactions.

A highly sensitive,

inexpensive, and rapid sensor utilizing the nuclear receptor PXR has been developed and
is demonstrated within. Recently, biosensors based on nanomechanical microcantilevers
(MCs) have been used to detect and screen for many harmful environmental
contaminants using estrogen and thyroid receptors (15, 20). The high sensitivity and
widespread availability of inexpensive MCs has generated intense interest in their use as
chemical and biological sensors (17, 18, 21, 50, 56, 92-94, 104, 109). Additionally, MCs
can be used with on-chip circuitry and in microcantilever arrays (MCAs) for high
throughput and simultaneous differential assays and bioaffinity studies with a very small
transducer footprint that potentially could be employed in the field.
A MC suitable for biosensing is modified on one side with some receptor phase
that has some degree of affinity for the analyte. By exploiting PXR’s affinity for a
diverse range of ligands, we are able to screen for xenobiotics and target specific
compounds quickly and without extensive, time-consuming labeling techniques and cell
preparation (39, 43, 79, 81, 120). Specific interactions of the target analytes with that
phase cause an apparent surface stress and nanomechanical bending that may be
conveniently monitored based on the beam bending technique commonly used in atomic
force microscopy. The static bending (tip deflection, zmax) of the MC varies in selectivity
and sensitivity due to preferential binding of analyte molecules on the functionalized,
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active MC surface and is governed by Stoney’s equation (14). See equation 4 in Chapter
1.
We demonstrate that detection based on nanomechanics for pharmaceuticals and
endocrine disrupting chemicals (EDCs) can be accomplished with functionalized MCs.
These measurements provide real-time measurements of surface stress changes in the
low-to-sub-nanomolar range (50). Sensitivity is critical when nanomechanical biosensing
is performed due to the ultra-trace concentrations of many xenobiotics that can impact
biological systems. Nanostructured MC biosensors allow detection without labels and in
a detection range that is applicable for real biological systems (112). PXR immobilized
on a nanostructured MC surface provides sensitive and reversible detection of various
pharmaceuticals and environmental contaminants or EDCs. To our knowledge, this is the
first time the orphan nuclear receptor PXR has been immobilized on a MC surface. Due
to PXR’s LBDs unique nature we saw interesting results in our concentration studies with
rifampicin as well as surprising responses when utilizing different tagged receptors.

4.2 Experimental
Experiments were performed using commercially available silicon arrays of MCs
having dimensions 400µm length, 100µm width, and approximately 1µm thickness
(Mikro Masch Co., Sunnyvale, CA). Chromium, gold, and silver metals deposited on the
MCs were obtained from Kurt J. Lesker, Gatewest, and Alfa Aesar Co., respectively, at
99.9% purity. 2-Aminoethanethiolhydrochloride (AET), glutaraldehyde (GA), the salts
employed for the preparation of buffer solutions, and all other reagents were purchased
from Sigma-Aldrich Chemical Co (St. Louis, MO) or Fisher at highest available purity
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and used as received. The EDCs, phthalic acid, nonylphenol and bisphenol A were also
obtained from Sigma-Aldrich.

The pharmaceuticals, rifampicin, pregnenolone-16α-

carbonitrile (PCN), and 3-methylcholanthrene (3-MC) were purchased from Sigma
Aldrich.

Glutathione-s-transferase (GST)-tagged human PXR was purchased from

Invitrogen (Carlsbad, California).

6-histidine (6-HIS)-tagged human PXR was

generously provided by Astra Zeneca. Ovalbumin was purchased from Sigma Aldrich.
Water used to prepare solutions was obtained from a Branstead E-pure water filtration
system.
The process of creating nanostructured surfaces on MCs is described in detail
elsewhere (49). The cantilevers were first cleaned in a piranha bath (75% H2SO4,
25% H2O2) for 30 minutes, followed by thorough rinsing in deionized water [Caution:
piranha solution reacts violently with organics]. The MCs were then placed into a
physical vapor deposition (PVD) chamber (Cooke Vacuum Products, Model CVE
301, South Norwalk, CT) to be coated on one side with the appropriate metallic films
using thermal deposition. To create a nanostructured MC, a thin film (~ 5nm) of
chromium was applied to the surface to act as an adhesion layer followed by a thin
film of gold (~15nm). Next, a film consisting of gold and silver was co-deposited.
Subsequently, the silver was chemically removed via oxidation from the film
(“dealloying”) using an aqueous solution of 5 mg/mL HAuCl4 leaving a gold surface
with nanosized, colloid-like features. The thickness of the dealloyed gold layer was
~100 or ~150 nm in these studies. Chapter 1 and Chapter 3 provide more information
on the background of nanostructured surfaces and optimized dealloyed conditions.
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Nanostructured MCs were chemically modified by immersion in 1mM aqueous
solution of AET for one hour producing a self-assembled monolayer of AET on the
cantilever surface. Following thorough rinsing in deionized water, the amino groups were
derivatized with the cross linker by immersing the cantilever in a 1% (w/v) solution of
GA in pH 8 10 mM phosphate buffered saline (PBS) for three hours (95, 115). The
chemically treated cantilever was allowed to soak in a large volume of water for a few
minutes to remove any nonspecifically bound GA on the nanostructured and silicon sides
of the cantilevers. Subsequently, immobilization of both the PXR nuclear receptor and
the ovalbumin was achieved in random orientation by dipping the functionalized
cantilevers into 100 mg/L solutions of receptor or protein in phosphate buffered saline
(PBS, 10mM, pH=7) for four hours. During functionalization with PXR, the MCs dipped
into the receptor samples were kept at 4°C to maintain activity. Both PXR and ovalbumin
were separately immobilized on the functionalized surfaces of different cantilevers from
separate arrays. After washing with PBS, the functionalized microcantilevers could be
stored in PBS at 4°C until it is used.
The MC deflection measurements were carried out using the optical beamdeflection technique. The apparatus included a 5 mW diode laser (Coherent Laser Corp.,
Auburn, CA) operating at 632 nm, a spatial filtering and focusing system, and an inhouse built position sensitive optical detector (Fig. 2). The output of the detector was
displayed and recorded using a SRS 850 DSP lock-in amplifier as a multichannel digital
recorder (Stanford Research Systems, Sunnyvale, CA). The signal output is recorded as
volts (approximately 1 nm zmax per mV output). Data was collected at 1 Hz and then a
moving averaging algorithm covering 180 data points was used to generate the figures
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presented herein. This smoothing did not alter the shape of the true response curves (92).
Chapter 1 provides more information on the static bending setup.
The cantilever system was mounted inside a ~5µL volume flow cell made of a
3 cm diameter by 2 cm long Delrin rod that was machined with 1/16 inch diameter
input and output holes that meet at 1 cm distance apart at the face of the rod. Narrow
bore tubing of 1/16 inch O.D. was slid into the holes up to the rod face and secured
with fittings. A semi transparent silicone gasket, which is slightly thicker than the
MC chip (~500µm versus 400µm), was cut with a scalpel tool to form a ~250 µm
wide flow channel between the input/output holes and to tightly hold the MC chip.
The silicone gasket is sandwiched between the Delrin rod face and a thin quartz
window. A Watec CCD camera (Edmund Industrial Optics, Barrington, NJ) was used
to image the MC chip in the flow cell (Fig. 8). The camera facilitated aligning the
focused laser beam to reflect off the cantilever tip. Analyte solutions were delivered
to the flow cell via a system of vessels connected to three-way valves allowing for
switching between different solutions. The gravity-driven flow was generally adjusted
to 100 µL/minute by adjusting vessel height.
Many of the pharmaceuticals and EDCs are sparingly soluble in water. Thus,
1×10-2M stock solutions of all EDCs and some pharmaceuticals were prepared in pure
methanol and then diluted with PBS (10mM Phosphate Buffer + 10mM NaNO3, pH =
7.0) to make the desired concentration of each analyte [Caution: because of their
potential harmful effects, care must be taken in the handling and disposing of EDC
and pharmaceutical solutions]. PCN pharmaceutical stock solution was prepared in
acetone. PBS was also used as a background solution. MCs mounted in the flow cell
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were initially allowed to equilibrate in PBS until the signal was stable. For our
purposes, tensile and compressive responses involve contraction and expansion of the
active MC surface, respectively.

4.3 Results and Discussion
Our studies focus on developing MC systems utilizing the nuclear receptor PXR
as the immobilized bioreceptor phase. We demonstrate that our immobilization process
does not appreciably denature the PXR. The magnitude based response order for PXR
activators is maintained when compared to well-established assays. With these PXR
active analytes, PXR selectivity is demonstrated when compared to a similarly sized
immobilized protein. The assay magnitude based response order is also maintained when
PXR is exposed to EDCs. Reproducibility and sensitivity is illustrated using a potent
PXR activator, rifampicin. To demonstrate the translation of receptor-ligand binding into
MC surface stress, we compare receptor tag size and amino acid residue makeup of two
tags, glutathione S-transferase (GST) and 6-histidine (6-HIS) tag. Our developing PXR
MC biosensor, in support of fundamental nuclear receptor studies, may prove to be a
quick, less expensive method for EDC screening and possible drug-drug interaction
predictions.
Sensitivity enhancement in biosensing is key due to the small concentrations of
ligands that can activate nuclear receptors. By nanostructuring the active MC surface, we
are able to substantially improve the sensitivity, which has in many cases surpassed the
increase in surface area (5, 17, 49). The initial “dealloying” of the MC surface provides a
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greater surface area for nuclear receptor immobilization, which leads to an enhancement
in sensitivity.
Fig. 20 compares the responses of a PXR functionalized MC when exposed to
three analytes in PBS. This figure illustrates that 1x10-6 M rifampicin is the most potent
PXR activator in this group. Our experiments in the detection of rifampicin using the
nuclear receptor, PXR, showed good measurement reproducibility in the same day tested
via three replicate consecutive injections of 1x10-6 M solution (see Fig. 20 inset).
Coefficients of variation (CVs) for measurements using a given system of MC and
molecular-recognition phase are generally 10% or better (15, 17, 21, 50, 92). The
relatively slow response kinetics is comparable to prior biosensor MC experiments (15,
21, 50). This provides strong evidence that the ligands interact with the LBD causing
conformational changes in the immobilized PXR, which translates into a large apparent
surface stress on the cantilever. The high binding affinity of human PXR for rifampicin
followed by PCN has been observed by other researchers (39, 43, 72, 73, 121, 122).
Although 3-MC is predicted to have a low binding energy to the LBD of human PXR
(123), it has been shown to be activated by members of the cytochrome P450 family of
enzymes, which include activating CYP1A1/2 enzymes (124-126).

The magnitude

response order of rifampicin > PCN > 3-MC is what we expected from the literature. In
our previous studies, the reversible compressive response is also observed for other
bioreceptor functionalized dealloyed surfaces whereas smooth gold MC shows an
irreversible compressive response on exposure to the same concentration of analytes (21,
50).
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Fig. 21 inset compares the response of specific protein (PXR) functionalized MC
to nonspecific protein (ovalbumin) functionalized MC (blank) on exposure to the same
concentration (1x10-6 M) of rifampicin. A large compressive response was observed due
to the binding of rifampicin with a MC modified with PXR receptor whereas no response
was observed when the same analyte was exposed to the nonbinding protein (ovalbumin)
immobilized MC. It is important to note that our system does not show a nonspecific
blank response.

This indicates that the surface immobilization procedure does not

significantly alter the PXR’s LBD function and selectivity. However, it can not be
assumed that the surface immobilized receptors will retain the same ligand binding
affinity as observed in free form.

Fig. 21 compares the specific and non-specific

response magnitude of 1x10-6 M rifampicin, PCN, and 3-MC to immobilized PXR and
ovalbumin (blank).
EDC exposure could be adverse even at very small concentrations (62). EDCs
can alter or inhibit the function of the endocrine system by binding to estrogen receptors,
which are part of the nuclear receptor superfamily (40, 58, 71). Studies have shown that
the nuclear receptor PXR binds to certain EDCs with different affinities (31, 127). Fig.
22 shows the nanomechanical response magnitude of PXR functionalized MCs on
exposure to 1x10-6 M EDCs, phthalic acid, nonylphenol, and bisphenol A. The response
magnitude order of PXR with these three EDCs is similar to prior work with phthalic acid
> nonylphenol and with relatively no response or a very low response to bisphenol A
(127). After MC exposure to EDCs, we injected 1x10-6 M rifampicin, a potent PXR
activator, for comparison. As predicted, the rifampicin caused a large compressive
response when compared to the EDCs (see inset).
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Fig. 23A demonstrates nanomechanical response profiles of PXR receptor
functionalized MC to different concentrations of rifampicin in the range of 0.1 nM to 1
µM where the response increases with increasing concentration. The response magnitude
does not increase as significantly as expected with increasing concentration. This may be
due to the structural flexibility of the LBD.

The expansion of the LBD size to

accommodate for rifampicin’s large size could have an effect on the interaction’s
translation to MC surface stress. Rifampicin is one of the largest known ligands for PXR
at 823 Da (81). It is also possible that once ligand binding rearrangement of the PXR
occurs, the protein does not quickly or completely reassume its original conformation
(renature) upon ligand removal. The kinetic response of the cantilever at 6.7 minutes of
exposure is plotted against concentration of rifampicin in Fig. 23B. As illustrated in the
figure, the response increased gradually and reached a plateau by 100 nM. The inset in
Fig. 23B shows a linear dynamic range for two orders of magnitude (the first data point
corresponds to the lowest concentration in Fig. 23B 0.1 nM) in concentration.
In our current functionalization procedure, the protein is immobilized on the MC
surface with GA without excessive denaturing of the protein (55). This is accomplished
by the aldehyde groups in the GA reacting with lysine residues in the receptor (54). This
makes the number and location of the lysine residues that make up the protein or receptor
important to our random immobilization process. The tags on the PXR LBD allows for
the purification of the receptor. The amino acids present in the tag and their location
could be beneficial or detrimental to our MC receptor functionalization. GST-tagged
human PXR LBD from Invitrogen has a calculated molecular weight of
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64.70 kDa. The approximate molecular weight of human PXR LBD is 37.35 kDa, which
leads to the calculated molecular weight for the GST-tag to be 27.35 kDa. The GST-tag
and the PXR LBD have similar molecular weights in this case. The 6-HIS-tag on the
Astra Zeneca LBD PXR is approximately 2524 Da and contains no lysine residues. The
GST-tag contains an estimated 21 lysine residues, depending on which version of the
GST was used in the preparation. 6-HIS-tagged PXR LBD was not bound to the surface
by the tag, but by the nuclear receptor itself, where as the much larger GST-tag could
have been the component bound on the MC surface. Fig. 24A compares the responses of
6-HIS-tagged LBD PXR and GST-tagged LBD PXR upon exposure to 1x10-6 M
rifampicin. The 6-HIS-tagged LBD PXR gives a large compressive response whereas the
GST-tagged LBD PXR shows no response. This indicates that the GST-tag may be
bound to the surface and could have the PXR too far from the surface. This distance
from the surface may not allow the conformational change upon ligand binding to
translate efficiently to measureable surface stress. The very small, lysine deficient 6HIS-tag requires the receptor to be surface bound and could easily transfer
conformational change to the MC surface. This is illustrated through a schematic in Fig.
24B.
In summary, a sensitive, selective, and reusable biosensor for the study of PXR
activating chemicals has been developed using nanostructured MCs. Our results indicate
that the interaction of LBD PXR with various ligands produced different cantilever
responses showing the maximum response for the antibiotic rifampicin.

PXR

functionalized MCs showed responses to rifampicin in concentrations down to 1x10-10 M.
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Dissimilarity in tag size and residue makeup also indicate differences in receptor-ligand
binding translation into MC surface stress.
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Chapter 5 Summary
The development of biosensors is critical to understanding complex biological
processes and pathways in the body. Understanding these processes can make it easier to
determine where, when, and possibly why diseases start and how they move through the
body. Since trace concentrations of contaminates can cause debilitating health problems,
screening and detection of these compounds may be crucial to lessening or eliminating
them from the environment.

The research presented in this work utilized

biofunctionalized MC sensors to study contaminate interaction with various receptors.
Chapter 2 presented estrogen receptor and antibody studies on various EDCs.
Nanostructured MCs were functionalized with two subtypes of estrogen receptor, ER-α
and ER-β, then exposed to naturally occurring and synthetic potential EDCs. ER-α and
ER-β showed different responses to each EDC, which followed the response magnitude
order of more established bioassays. An EDC specific antibody was immobilized on DA
MCs which responded with high sensitivity and selectivity to the specific EDC and
showed very little interaction with non-specific ligands. These studies help demonstrate
that immobilizing bioreceptors on the MC surface allow the receptor to maintain some of
it’s ligand binding capabilities and it’s ability to distinguish between various ligands.
Chapter 3 focused on optimizing DA morphology and chemical immobilization of
proteins. The nanostructured surface and the chemical linking of the protein to the MC
can influence the sensitivity, selectivity, and reversibility of the biofunctionalized MC
sensor. Optimizing the MC surface and immobilizing conditions may help improve the
MC biosensor performance. The dealloying parameters, which include thickness and
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metal ratio, were initially optimized with the model test system, anti-IgG-IgG. Proteins
are chemically immobilized with a SAM of AET and GA linkage. Chemical linking
conditions were optimized including concentration, pH, and reaction time by testing with
the same model test system as the DA. Protein incubation time and conditions were
optimized with two model test systems, which are anti-IgG-IgG and anti-biotin-biotin.
This was to include large ligands and small ligands, which are called haptens. The
optimized conditions for the model test system, anti-IgG-IgG, are as follows: 50 Au: 50
Ag 150 nm DA, 1 mM aqueous solution of AET with a 1 hour reaction time, 1% GA
solution in 10 mM PBS pH 8 with a 3 hour reaction time, 0.5 mg/mL anti-IgG in 10 mM
PBS pH 7 with an incubation time of 1 hour.

The optimized and non-optimized

conditions were applied to detecting TDCs with the thyroid transport protein, TBG. The
selectivity pattern for various TDCs followed the response magnitude patterns established
by other researchers’ studies.

Surprising results were obtained when performing

orientation studies with protein A on anti-IgG and IgG functionalization, indicating that
specific orientation of the immobilized protein may not always yield better responses
than randomly orientated immobilized proteins.
Chapter 4 studied EDC and pharmaceutical interactions with the orphan nuclear
receptor PXR. PXR plays an important role in metabolizing endogenous compounds to
remove them from the body. Immobilizing PXR onto the nanostructured MC surface
allowed for the study of ligand interaction with PXR’s LBD. PXR functionalized MC
interaction with the antibiotic rifampicin, a known PXR activator, was studied.
Pharmaceutical and chemical interaction was studied with PXR and also a similarly sized
non-specific protein, ovalbumin, to show the selectivity of the interactions.
98

PXR

functionalized MCs were also exposed to EDCs, which demonstrated that the response
magnitude order for the EDCs is similar to prior assay studies. The tag size and residue
makeup was studied on immobilized PXR to illustrate the importance of receptor
conformational change upon ligand binding translating into MC surface stress.
Coefficients of variation (CVs) for measurements using a given system of MC
and biological molecular-recognition phase are generally 10% or better (15, 20, 21,
50). The immunosensor for human interleukin-1 β (HILI-β) Ab on exposure to HILIβ antigen showed a CV of 10% of triplet replicate intra day injections (50). In
stereoselective detection, we have shown detection of chiral amino acids with
antibody immobilized MCs with excellent same day reproducibility (CV=2%) (9).
For endocrine disrupting chemical sensing, we have demonstrated CVs of 2.4% and
3.1% for triplicate replicate consecutive intra-day injections of 17-β-estradiol with
estrogen receptor β and 17-β-estradiol antibody (15).

ER-β functionalized MC

arrays prepared in different batches showed 8-10% CV values in the detection of
different concentrations of 17-β- ES.
To investigate stability, anti-17-β-ES Ab functionalized MC was exposed to
1×10-9 M of 17-β-ES at three different periods after storing in PBS at 4°C (2-nd, 4-th,
and 8-th day after functionalization), an average value of deflection on day 4 and day 8
were 97% and 76% of the initial response, respectively. Similarly, the stability of ER-β
functionalized MC was studied over periods of 5 days after storing in PBS at 4°C
wherein it showed poorer stability; exposure to 1×10-9 M of 17-β-ES yielded responses
after 3 and 5 days that were 78% and 36% of the initial response, respectively. Also, the
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stability of ER-functionalized MC was tested at 4°C varying the environment (stored dry
versus in PBS).

The results showed that the immobilized antibody retained it’s

functionality for a longer period of time (7-10 days after functionalization) if stored dry at
4°C whereas it can be stored in PBS for near immediate use. Surprisingly, in both of the
experiments performed, the response actually increased by a factor of two after one week
of dry storage at 4°C. LBD PXR functionalized MC on exposure to intra-day triplicate
sequential injections of 1x10-6 M rifampicin showed a CV of 6.32%. In general, good
reproducibility is seen for bioreceptor functionalized nanostructured MCs.
The research presented in this work is the beginning of creating complex bioarray
sensors that can better mimic biological systems. The promise of creating label-free
bioarrays comprised of nuclear receptors and antibodies to study their simultaneous
interactions with contaminants and pharmaceuticals with real-time measurement could be
an important step to better understanding some biological pathways. A bioarray could
help in studying contaminate-drug and drug-drug interactions, which is critical in
pharmaceutical development and contaminate screening. Bioarrays may also be useful in
studying mixtures of analytes, yielding information about specific interactions with
receptors and may show that competitive interactions could occur in our system. Future
work could also involve studying the aspects of analyte saturation of the immobilized
receptor and this saturation effect on receptor recovery upon buffer introduction.
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Appendix: Development of a Nanomechanical
Biosensor for Analysis of Endocrine Disrupting
Chemicals
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Experimental
Aminoethanethiolhydrochloride (AET), glutaraldehyde (GA), the salts employed
for the preparation of buffer solutions, and all other reagents were purchased from SigmaAldrich Chemical Co (St. Louis, MO) or Fisher at highest available purity and used as
received. The proteins human immunoglobulin G (hIgG, reagent grade), protein A, and
anti- human IgG were also obtained from Sigma-Aldrich.
Smooth gold (40nm) and dealloyed (50nm, 100nm, and 200nm) MCs were
prepared (See Cantilever Modification in the main text) and functionalized with antihuman IgG antibody. Random functionalization (without protein A) of both the antihuman IgG antibody and human IgG was achieved by dipping the AET and GA
functionalized MCs (see the Cantilever Modification under Experimental section in the
main text) into 50mg/L solutions of protein in 10 mM phosphate buffered saline (PBS,
pH 7) for 5 hours. Oriented functionalization (with protein A) was performed as follows.
Initially, the AET and GA functionalized cantilevers were dipped into 100mg/L solutions
of protein A in PBS for 1 hour, washed with PBS for several times and then the protein A
functionalized cantilevers were dipped into 50mg/L solutions of anti-human IgG/human
IgG

in PBS for 5

hours.

Both proteins were separately immobilized on the

functionalized surfaces of different cantilevers from different microcantilever arrays.
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Results and Discussion
Response characteristics of nanostructured MCs
Fig. Appendix-1 shows comparison of bending responses of antibody
functionalized nanostructured MC to similarly functionalized smooth gold MC using anti
human IgG antibody. When the nanostructured MC, functionalized with anti human IgG
antibody was exposed to 50mg/L of human IgG, specific interaction of antibody-antigen
exhibited 480mV (~380nm) cantilever tip deflection that corresponds to a compressive
surface stress change. Upon flushing the cell with background buffer, the response was
reversed. Conversely, similarly functionalized MC with a smooth gold surface shows a
largely irreversible compressive response on exposure to the same concentration of
human IgG; which was also observed by other researchers for specific interactions of
different antibody-antigen pairs (See references 18, 56, and 100). When comparing a
smooth to a nanostructured MC surface, 50nm dealloyed gold coating increases MC
response by roughly a factor of two. In some prior applications not involving bioaffinity
functionalized MC, the nanostructuring resulting in as much as 2-3 orders of magnitude
enhancements in chemi-mechanical responses (References 17 and 49 show direct
comparisons of dealloyed versus smooth gold surfaces) for both self-assembled
monolayers and thin films of responsive phases. Some of this enhancement in response
has been attributed to increased surface area for the nanostructured surfaces.
The reversibility of response for the nanostructured MC, despite very high
sensitivity (see Figure 11 for example), is surprising and counter to the expected large
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Fig. Appendix-1. Comparison of bending signals of anti human IgG

antibody functionalized nanostructured (dealloyed) MC to similarly
functionalized smooth gold MC.

111

affinity constants. The morphology and chemical nature of these two types of MC
surfaces are not the same and perhaps chemical attachment of the bioreceptor in the
dealloyed case shows a decrease in affinity constants that is compensated by the inherent
larger responses of the large surface area nanostructured MC. It is also worth noting that
we do not allow the establishment of equilibrium upon exposure to analyte (sampling
only occurs for several minutes before we return to buffer flow). Long term exposure to
the sample may not show the same reversibility. In any event, the fortuitous nature of
high sensitivity with reversibility is a unique and valuable attribute of our bioaffinity
nanomechanical sensing approach.
Concurrent with the studies described in the main text, we performed some
optimization studies involving the dealloying process. Fig. Appendix-2 demonstrates the
responses of anti human IgG antibody functionalized dealloyed MCs with different
thicknesses of the dealloyed surfaces. On exposure to 0.05mg/mL of hIgG in 10 mM pH7
PBS for 10 minutes, antibody functionalized MCs showed increased response with
increasing thickness of the dealloyed MCs. The response of the antibody functionalized
100nm and 200nm dealloyed MCs are 2.5 and 5 fold greater, respectively, than the
response of the similarly functionalized 50nm dealloyed MCs.

The work with EDC

receptors was performed with the thinner 50nm dealloyed layer, thus even greater
sensitivity than is demonstrated in the main text for EDC detection may be possible.

Random and Oriented functionalization of antibody and antigen
Both oriented and randomly functionalized MCs with anti human IgG or human
IgG showed reversible compressive stress responses (expansion of the active surface) on
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exposure to different concentrations of human IgG (0.001mg/mL) or anti human IgG
(0.05mg/mL) in PBS. It is interesting to observe that the random functionalization shows
a three times larger response than the oriented case when the cantilever is functionalized
with anti human IgG antibody. Conversely, when MC is functionalized with human IgG,
oriented functionalization shows greater response than the random one when exposed to
the antibody (See Table Appendix-1). These two different experiments demonstrate that
proper orientation of bioreceptor proteins on the MC surface do not always yield
improvements in response, presumably because of the stress induction response
requirement (i.e. conformational changes upon analyte binding are important but
depending on the nature of the linkage to the MC surface this conformational change may
not translate into a large apparent surface stress). Note that both this specific monoclonal
antibody and the protein A (the protein A may act in some cases as a spacer that reduces
the induction of stress) are specific for the Fc portion of the IgG protein. Because of
these complications, affinity constants determined by the nanomechanical approach
would only be apparent ones and of only minor significance.
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With
Protein A
Without
Protein A

Antibody
functionalized MC
0.001mg/mL
human IgG
(5 mins response)
(V)
0.043

Antigen
functionalized MC
0.05mg/mL
anti human IgG
(5mins response)
(V)
0.518

0.126

0.321

Table Appendix-1. Comparison of the response of antibody and antigen

functionalized MC on exposure to antigen/antibody with random (without
Protein A) and oriented (with Protein A) functionalization.
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